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ABSTRACT 30 
 31 
Porcine reproductive and respiratory syndrome (PRRS) is an economically devastating 32 
viral disease affecting swine industry worldwide. Its viral etiological agent, porcine reproductive 33 
and respiratory syndrome virus (PRRSV), possesses a RNA viral genome which contains nine 34 
open reading frames (ORFs). The ORF1a and ORF1b replicase-associated genes encode the 35 
polyproteins pp1a and pp1ab, respectively. The pp1a is processed in nine non-structural proteins 36 
(nsp): nsp1α, nsp1β, and nsp2 to nsp8. Proteolytic cleavage of pp1ab generates products nsp9 to 37 
nsp12. The pp1a cleavage products possess proteolytic activities and are responsible for the 38 
processing and cleavage of pp1a and pp1ab into nsp products; whereas nsp9 to nsp12 are 39 
involved in virus transcription and replication. The 3’ end of the viral genome encodes four 40 
minor and three major structural proteins. The GP2a, GP3 and GP4 (encoded by ORF2a, 3, and 4), 41 
are glycosylated membrane associated minor structural proteins. The fourth minor structural 42 
protein, the E protein (encoded by ORF2b), is an unglycosylated and membrane associated 43 
protein. The viral envelope contains two major structural proteins: a glycosylated major envelope 44 
protein GP5 (encoded by ORF5), and an unglycosylated membrane M protein (encoded by 45 
ORF6). The third major structural protein is the nucleocapsid N protein (encoded by ORF7). All 46 
PRRSV non-structural and structural proteins are essential for virus replication, and PRRSV 47 
infectivity is relatively intolerant to subtle changes within the structural proteins. Overall, the 48 
available data indicate that PRRSV virulence is multigenic and resides in both the non-structural 49 
and structural viral proteins. In the following manuscript, the molecular characteristics, 50 
biological and immunological functions of the PRRSV structural and non-structural proteins and 51 
their involvement in the virus pathogenesis are summarized. 52 
  3
INTRODUCTION 53 
 54 
Porcine reproductive and respiratory syndrome (PRRS) is present worldwide and is the 55 
most economically important infectious disease of swine production (Neumann et al., 2005). 56 
PRRS disease was first described in the United States in 1987 (Keffaber, 1989; Loula, 1991)   57 
and a few years later in the Netherlands (Wensvoort et al., 1991). The disease has many clinical 58 
manifestations but the two most prevalent are severe reproductive failure in sows and gilts 59 
(characterised by late-term abortions, an increased number of stillborns, mummified and weak-60 
born pigs) (Albina, 1997; Bilodeau et al., 1991; Christianson, 1992; Keffaber, 1989; Loula, 61 
1991; Pol et al., 1991) and respiratory problems in pigs of all ages associated with a non-specific 62 
lymphomononuclear interstitial pneumonitis (Albina, 1997; Bilodeau et al., 1991; Collins et al., 63 
1992; Halbur et al., 1996b; Keffaber, 1989; Loula, 1991; Rossow, 1994).  64 
The etiological agent, porcine reproductive and respiratory syndrome virus (PRRSV) was 65 
identified in 1991 by investigators in the Netherlands and shortly after in the United States 66 
(Benfield et al., 1992; Collins et al., 1992; Wensvoort et al., 1991). The PRRSV is an enveloped, 67 
single-stranded positive sense RNA virus, approximately 50–65 nm in diameter that is classified 68 
in the order Nidovirales, family Arteriviridae, genus Arterivirus along with equine arteritis virus 69 
(EAV), lactate dehydrogenase-elevating virus of mice (LDV), and simian hemorrhagic fever 70 
virus (SHFV) (Benfield et al., 1992; Cavanagh, 1997). PRRSV genome is approximately 15 kb 71 
in length. The RNA viral genome is capped at the 5’ end and polyadenylated at the 3’ termini 72 
and encodes at least nine open reading frames (ORFs) (Dea et al., 2000a), each of which is 73 
expressed via the generation of a 3’-coterminal nested set of subgenomic (sg) mRNAs (Allende 74 
et al., 1999; Gorbalenya et al., 2006). ORFs1a and 1b, which take almost 2/3 of the genome, 75 
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encode non-structural proteins (nsp), such as RNA polymerase, that are required for virus 76 
replication (Allende et al., 1999). At least 12 nsps are generated as a result of serial cleavages of 77 
two polyproteins expressed from ORF1a and ORF1ab, which RNA is transcripted by a ribosomal 78 
frame shift between ORF1a and 1b (Snijder, 1998; Snijder, Meulenberg, 1998). Three N-79 
glycosylated minor envelope proteins (GP2a, GP3, and GP4) are translated from ORF2a, 3, and 4 80 
and form heterotrimers by disulfide linkage (Wissink et al., 2005). ORF2b, which is completely 81 
embedded in ORF2a, encodes another non-glycosylated minor protein named E (Wu et al., 82 
2001). ORF5 encodes the major envelope glycoprotein (GP5) that forms a heterodimer with the 83 
membrane non-glycosylated protein (M) encoded by ORF6 (Mardassi et al., 1996). The viral 84 
capsid is composed of only one nucleocapsid protein (N), which is encoded by ORF7 and is 85 
highly immunogenic in infected animals (Dea et al., 2000a). 86 
 87 
The virus is genetically, antigenically, and pathogenically heterogenic (Dea et al., 2000a; 88 
Meng, 2000). Currently, PRRSV isolates are divided into two distinct genotypes, represented by 89 
Lelystad virus (LV) in Europe (Wensvoort et al., 1991) and ATCC VR-2332 in North America 90 
(Benfield et al., 1992; Dea et al., 1992). Even though European (EU) and North American (NA) 91 
isolates possess several biological and immunological similarities, including a nearly identical 92 
genome organization, both strains are genetically and antigenically distinct (Magar et al., 1995; 93 
Mardassi et al., 1994a; Nelsen et al., 1999). Sequence analyses have shown approximately a 60% 94 
nucleotide identity between the Type I (European - EU) and Type II (North American - NA) 95 
genotypes (Allende et al., 1999; Forsberg, 2005; Hanada et al., 2005; Nelsen et al., 1999; 96 
Plagemann, 2003). Several studies have shown that a high degree of genetic variability exists 97 
within the NA-type of PRRSV (Andreyev et al., 1997; Gagnon, Dea, 1998; Kapur et al., 1996; 98 
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Meng et al., 1995a; Morozov et al., 1995; Pirzadeh et al., 1998). While early studies suggested 99 
that a lower degree of variability might exist in EU PRRSV type (Drew et al., 1997; Suarez et al., 100 
1996b), later studies in some countries, such as Denmark and Italy, have reported a high 101 
divergence within EU-type isolates (Forsberg et al., 2001; Forsberg et al., 2002; Madsen et al., 102 
1998; Nielsen et al., 2000; Oleksiewicz et al., 2000). Recently, the emergence of potential highly 103 
pathogenic variant of PRRSV as the possible cause for large-scale outbreaks with high mortality 104 
in China was reported in 2006 (Li et al., 2007; Tian et al., 2007). It is now obvious that PRRSV 105 
isolates showed considerable genetic variation and could be classified in several phylogenetic 106 
clusters within each genotypes (Fang et al., 2007; Kiss et al., 2006; Mateu et al., 2006; Yoshii et 107 
al., 2005).  108 
 109 
In the following manuscript, the molecular characteristics, biological and immunological 110 
functions of the PRRSV structural and non-structural proteins and their involvement in the virus 111 
pathogenesis are described.  112 
 113 
Virus morphogenesis 114 
 115 
Earlier studies indicate that the N protein forms a spheric icosahedral capsid core of 20-116 
30 nm in diameter, which is surrounded by a lipid envelope containing the viral envelope 117 
proteins, yielding a relatively smooth spherical virion of about 60 nm in diameter (Benfield et al., 118 
1992; Dea et al., 2000a; Doan, Dokland, 2003a, b). Recently, Spilman et al. (Spilman et al., 119 
2009) have described the structure of PRRSV virions based on cryo-electron microscopy (EM) 120 
analysis and tomographic reconstruction of virions grown in MARC-145 cells. They have 121 
reported that the virus has a pleomorphic morphology, a spherical to oval shape with a size 122 
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ranging from about 50 to 65 nm, a hollow, layered core of around 40 nm diameter and a smooth 123 
outer surface studded with a few envelope protein complexes. The structural analysis indicates 124 
that the PRRSV core consists of an helical nucleocapsid (see schematic representation in Figure 125 
1) wrapped up into a hollow ball (Spilman et al., 2009), unlike previously mentioned studies 126 
(Benfield et al., 1992; Dea et al., 2000a; Doan, Dokland, 2003a, b). The latest results are not 127 
surprising since other members of the Nidovirales, such as coronavirus, have been known to 128 
possess a helicoidal capsid. Being an enveloped virus, PRRSV survivability outside the host is 129 
affected by temperature, pH and exposure to detergents. It is known that PRRSV can survive for 130 
extended intervals at temperatures ranging from -70 to -20OC (Benfield et al., 1992); 131 
nonetheless, viability decreases with increasing temperature. Specifically, recovery of PRRSV 132 
has been reported for up to 20 min at 56OC, 24h at 37OC, and 6 days at 21 0C (Benfield et al., 133 
1992). The PRRSV remains stable at pH ranging from 6.5 to 7.5 but, infectivity is reduced at 134 
pH<6.0 or >7.65 (Bloemraad et al., 1994). Detergents are effective at reducing infectivity of the 135 
virus and lipid solvents such as chloroform and ether are particularly efficient at disrupting the 136 
viral envelope and eliminate infectious virions (Benfield et al., 1992). Even if PRRSV is 137 
relatively fragile in the environment, appropriate weather (wind, TOC, humidity, etc.) may favour 138 
the transmission of the virus through aerosols up to 4.7 km distance (Dee et al., 2009). 139 
 140 
Cells pathogenesis 141 
 142 
PRRSV is generally believed to have a very restricted cell tropism both in vivo and in 143 
vitro. In vivo, the virus mainly infects well-differentiated cells of the monocyte-macrophage 144 
lineage, in particular porcine alveolar macrophages (PAM), the primary target cells of virus and 145 
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interstitial macrophages in other tissues such as heart, thymus, spleen and Peyer's patches, 146 
hepatic sinusoids, renal medullary interstitium, and adrenal gland (Beyer et al., 2000; Duan et al., 147 
1997; Halbur et al., 1995; Halbur et al., 1996b). In addition to macrophages, PRRSV RNA and 148 
nucleocapsid protein were found by in situ hybridization (ISH) and immunohistochemistry, 149 
respectively, in testicular germ cells, endothelial cells in the heart, interdigitating cells in the 150 
thymus, dendritic cells in the spleen and Peyer's patches (Halbur et al., 1996b; Sur et al., 1997). 151 
In experimentally infected gnotobiotic pigs, PRRSV antigens were found in bronchiolar 152 
epithelial cells, arteriolar endothelial cells, monocytes as well as interstitial, alveolar, and 153 
intravascular macrophages using an immuno-gold-silver immunohistochemical staining (Rossow 154 
et al., 1996). PRRSV RNAs and antigens were also found in bronchiolar epithelial cells (Pol et 155 
al., 1991), epithelium-like cells of alveolar ducts (Magar et al., 1993), and pneumocytes (Cheon 156 
et al., 1997; Pol et al., 1991) in the naturally infected pigs whereas it was not found in these types 157 
of cells in the experimentally infected pig (Teifke et al., 2001). Tissues such as lung, lymphoid 158 
tissues, Peyer’s patches, and kidney were also the preferable organ targets of PRRSV infection 159 
(Haynes et al., 1997; Sur et al., 1996).  160 
PRRSV was originally isolated on primary cultures of PAMs (Wensvoort et al., 1991) 161 
and so far, these cells as well as blood monocytes (Voicu et al., 1994), remain the only porcine 162 
cells that can effectively be used for viral propagation. Two non-porcine permissive cell 163 
subclones of MA104 monkey kidney cell line, the MARC-145 and CL2621 cells (Bautista et al., 164 
1993; Benfield et al., 1992; Kim et al., 1993) are also routinely used for in vitro propagation of 165 
wild and vaccine PRRSV strains. Flow cytometric and fluorescence antibody (FA) analyses of 166 
PRRSV antigen expression revealed distinct primary and secondary infection phases in MARC-167 
145 cells (Cafruny et al., 2006). PRRSV antigen is randomly expressed in a small amount of 168 
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cells during the primary phase of infection (up to about 20–22 h p.i.), but the logarithmic 169 
infection phase (days 2–3 p.i.) is characterized by secondary spread to clusters of cells. The 170 
formation of secondary clusters of PRRSV-infected cells preceded the development of CPE in 171 
MARC-145 cells. The primary and secondary PRRSV infection phases are inhibited by 172 
colchicine and cytochalasin D, which demonstrate a critical role of the cytoskeleton in viral 173 
permissiveness as well as cell-to-cell transmission (Cafruny et al., 2006). Cellular expression of 174 
actin also appeared to correlate with PRRSV resistance, suggesting a second role of the actin 175 
cytoskeleton as a potential barrier to cell-to-cell transmission (Cafruny et al., 2006).  176 
How the virus enters into the cells was firstly reported in 1996 (Kreutz, Ackermann, 177 
1996). It was postulated that since the direct fusion of the PRRSV envelope with the cellular 178 
membrane was not observed at any time, PRRSV entry most occurs by receptor-mediated 179 
endocytosis. In 1998, this hypothesis was confirmed (Duan et al., 1998) and a PRRSV receptor 180 
was identified on PAM by generation of PAM-specific monoclonal antibodies. Several viral 181 
receptors for PRRSV have been described, including heparin sulphate for binding, sialoadhesin 182 
for binding and internalization, and vimentin (Delputte, Nauwynck, 2004; Delputte et al., 2007a; 183 
Delputte et al., 2007b; Delputte et al., 2002; Kim et al., 2006). However, additional factors are 184 
needed because the expression of both receptors in non-permissive cells results in virus 185 
internalization but not in virus uncoating and productive infection. Recently, a molecule that is 186 
expressed exclusively on cells of a monocytic lineage the CD163, has been identified as a 187 
possible cellular receptor for PRRSV (Calvert et al., 2007; Patton et al., 2009; Van Gorp et al., 188 
2008). Furthermore, susceptibility of macrophages to PRRSV infection was previously shown to 189 
be associated with high expression of CD163 (Lopez-Fuertes et al., 2000). The role of CD163 190 
and its interaction with sialoadhesin during PRRSV infection of macrophages were investigated 191 
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(Van Gorp et al., 2008). Both sialoadhesin and CD163 are involved in infection of macrophages 192 
with different PRRSV strains (Van Gorp et al., 2008). Thus, sialoadhesin is confirmed as a 193 
PRRSV internalization receptor and CD163 is shown to be involved in PRRSV infection, 194 
probably during uncoating (Van Gorp et al., 2008). Finally, non-permissive cells expressing both 195 
sialoadhesin and CD163 are clearly more susceptible to PRRSV infection and produce more 196 
virus (10 to 100 time more) compared with cells expressing only CD163 (Van Gorp et al., 2008). 197 
The interaction between the viral glycoproteins and CD163 receptor where characterized using 198 
co-immunoprecipitation (co-IP) assay using monospecific antibodies (Das et al., 2010). It was 199 
found that the GP2a and GP4 proteins interact with the CD163 molecule (Das et al., 2010). The 200 
carboxy-terminal 223 residues of CD163 molecule are not required for interactions with either 201 
the GP2a or the GP4 protein, although these residues are required for conferring susceptibility to 202 
PRRSV infection in BHK-21 cells. Overall, it was postulated that the GP4 protein is critical for 203 
mediating interglycoprotein interactions and along with GP2a, serves as the viral attachment 204 
protein that is responsible for mediating interactions with CD163 for virus entry into susceptible 205 
host cell (Das et al., 2010). The CD151 molecule was identified by RNA-ligand screening of a 206 
MARC-145 cell expression library to be a PRRSV 3' UTR RNA-binding protein 207 
(Shanmukhappa et al., 2007). The CD151 is a member of the tetraspanin superfamily, which has 208 
several cellular functions that include cell signaling, cell activation and platelet aggregation 209 
(Fitter et al., 1999; Hasegawa et al., 1998; Sincock et al., 1999). Transfection of CD151 rendered 210 
BHK-21, a non-susceptible cell line, susceptible to PRRSV infection. The transfection of siRNA 211 
against CD151 inhibited PRRSV infection into MARC-145 cells. Additionally, polyclonal anti-212 
CD151 antibody (Ab) completely blocked PRRSV infection into MARC-145 cells 213 
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(Shanmukhappa et al., 2007). These results suggest that CD151 plays a critical role in PRRSV 214 
infection in vitro.  215 
PRRSV induces apoptosis both in vitro and in vivo (Choi, Chae, 2002; Kim et al., 2002; 216 
Labarque et al., 2003; Miller, Fox, 2004; Sirinarumitr et al., 1998; Suarez et al., 1996a; Sur et al., 217 
1997; Sur et al., 1998). PRRSV infection of both MARC-145 cells and PAM results in apoptosis 218 
which is characterized by morphological changes, DNA fragmentation and specific caspase 219 
activation. PRRSV seem to be able to induce apoptosis directly (in infected cells) or indirectly 220 
(in bystander non infected cells) in infected animals. For example, GP5 protein of PRRSV has 221 
been shown to be an apoptosis inducer in GP5 expressing cells (Gagnon et al., 2003; Suarez et 222 
al., 1996a). However, others have shown that PRRSV induces apoptosis mostly in uninfected 223 
bystander cells both in vitro and in vivo and that the majority of apoptotic cells in lung lavages, 224 
lungs, and lymphoid tissues are not positive for PRRSV antigens and RNA (Choi, Chae, 2002; 225 
Kim et al., 2002; Labarque et al., 2003; Miller, Fox, 2004; Sirinarumitr et al., 1998; Suarez et al., 226 
1996a; Sur et al., 1997; Sur et al., 1998). It was reported that alveolar macrophages from 227 
PRRSV-infected pigs show a significantly increased apoptotic rate (22–34%) compared to 228 
porcine circovirus 2 infected alveolar macrophages (3%) (Chang et al., 2005). Given the fact that 229 
only 5–10% of alveolar macrophages were PRRSV-infected, these authors suggested that TNF-α 230 
or GP5 released from PRRSV-infected cells induce apoptosis in non-infected cells. Another 231 
study from the same group demonstrated that increased FasL expression in PRRSV-infected 232 
macrophages caused apoptosis in co-cultured swine splenic lymphocytes (Chang et al., 2007). A 233 
previous report showed that the majority of apoptotic cells are characterized by both early and 234 
late apoptosis markers (Lee, Kleiboeker, 2007). Ultimately, these authors demonstrated that 235 
PRRSV induce apoptosis through a mitochondrial-mediated pathway. Two oppositely directed 236 
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sets of reactions are switched on in PRRSV-infected macrophages in vitro: at first, the balance is 237 
driven towards anti-apoptosis, but finally, PRRSV-infected macrophages die by apoptosis 238 
(Costers et al., 2008). Both anti- and pro-apoptotic effects were not only observed in PRRSV-239 
infected macrophages, but also in PRRSV-infected MARC-145 cells (Costers et al., 2008).  240 
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The nucleocapsid protein (N) 241 
 242 
The unglycosylated N protein possesses 123 to 128 amino acids (aa) depending on the 243 
genotype of the strains (NA versus EU, respectively) with a molecular weight of 15 kDa, and is 244 
encoded by ORF7 viral gene (Figure 2). The N protein of PRRSV is a multifunctional protein 245 
(Table 1). It is a basic protein with an isoelectric point of 10.4 and was shown to be a serine 246 
phosphoprotein (Wootton et al., 2002). Given that EAV and coronavirus nucleocapsid proteins 247 
are also phosphoproteins (Laude et al., 1995; Zeegers et al., 1976), phosphorylation of the 248 
nucleocapsid protein appears to be a common feature of nidoviruses. Phosphorylation of the N 249 
protein occurs, at position 120 (Figure 3) in PRRSV-infected cells and also in ORF7 gene-250 
transfected cells, where the N protein is synthesized in the absence of other viral components 251 
(Wootton et al., 2002). Evolutionary conservation of this post translational modification suggests 252 
that phosphorylation of the N protein may be of significant biological importance for the virus 253 
and, therefore, it warranties further investigation. Multifunctional proteins are often regulated by 254 
phosphorylation, and this phenomenon is particularly common to positively charged, nucleic 255 
acid binding proteins that make up the nucleocapsids of the coronavirus (Laude et al., 1995; Yoo 256 
et al., 1992), hepatitis B virus (Roossinck, Siddiqui, 1987), influenza virus (Arrese, Portela, 257 
1996; Yang, Zhang, 1999), rabies virus (McNabb, Courtney, 1992; Yang, Zhang, 1999), herpes 258 
simplex virus (McNabb, Courtney, 1992), and parvovirus (Maroto et al., 2000). Since it is well 259 
documented that phosphorylation is involved in regulating the activities of proteins at multiple 260 
levels, including nucleic acid binding, oligomerization, and nuclear transport, phosphorylation 261 
may likewise affect these properties of the PRRSV N protein. 262 
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The N protein is highly immunogenic in pigs (Loemba et al., 1996; Meulenberg et al., 263 
1995a, b) and in mice (Drew et al., 1995; Nelson et al., 1993; Rodriguez et al., 1997; van 264 
Nieuwstadt et al., 1996). Several groups have generated anti-N monoclonal antibodies (mAbs) 265 
that recognise epitopes specific to or shared by NA and EU isolates (Dea et al., 1996; Drew et 266 
al., 1995; Meulenberg et al., 1998; Nelson et al., 1993; Wootton et al., 1998). Based on the 267 
immunoreactivity of N protein deletion mutants with panels of N-specific mAbs, five domains of 268 
antigenic importance have been identified for a reference NA strain, four of them being localized 269 
at aa 30 to 52, 37 to 52, 69 to 112, and 112 to 123, respectively (Figure 3). Other mAbs revealed 270 
the presence of a common conformational antigenic site localised in the central region (aa 52–271 
69) of the protein (Rodriguez et al., 1997; Wootton et al., 1998). Mutational analysis revealed 272 
that the carboxyl-terminus of N plays a critical role in the formation of the conformational 273 
epitopes, and a domain comprised of the 11 C-terminal-most aa (residues 112 to 123) (Figure 3) 274 
was shown to be essential for binding of N-specific conformation-dependent mAbs (Meulenberg 275 
et al., 1998; Wootton et al., 2001; Wootton et al., 1998). The region between aa 37 and 52 is well 276 
conserved among isolates of both genotypes and is the most hydrophilic region of the protein 277 
(Figure 3). None of the N-specific mAbs have been found to be associated with virus 278 
neutralisation. Four distinct antigenic domains were identified for the reference EU LV strain 279 
(Meulenberg et al., 1998). Three sites, designated A–C, contain linear epitopes, and these were 280 
mapped between aa 2–12, 25–30, and 40–46, respectively. However, the fourth region, 281 
designated domain D, contains conformation-dependent or discontinuous epitopes that are 282 
(partially) composed of aa 51–67 and 80–90 (Meulenberg et al., 1998). The early immunological 283 
response generated in PRRSV-infected pigs is directed mainly against the N protein, and this 284 
response, which can be detected as early as one week postinfection (Loemba et al., 1996), 285 
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declines at a much lower rate than the one directed against the major structural proteins M and 286 
GP5 (Yoon et al., 1995). Since the majority of antibodies produced during PRRSV infection in 287 
pigs are directed against the N protein, for which major antigenic determinants are highly 288 
conserved, the N protein has been targeted as a suitable candidate for the detection of virus-289 
specific antibodies and diagnosis of the disease.  290 
One of the fundamental role of the viral capsid protein is to provide a protective 291 
enclosure for the viral genome during the extracellular phase of the virus life cycle. The N 292 
protein is the sole component of the viral capsid and interacts with itself through covalent and 293 
non-covalent interactions (Wootton, Yoo, 2003). NA PRRSV N protein contains three highly 294 
conserved cysteine residues at aa positions 23, 75 and 90. Systematic mutation of the three 295 
cysteine residues at positions 23, 75, and 90, either alone or in combination, revealed that the 296 
cysteine at position 23 (Figure 3) is involved in the formation of intermolecular disulfide bonds 297 
between N proteins (Wootton, Yoo, 2003). Subsequently, the functional significance of the N 298 
cysteine residues for PRRSV infectivity was assessed using an infectious cDNA clone (Lee et 299 
al., 2005). Each cysteine at positions 23, 75, and 90 was replaced with serine and the individual 300 
mutation was incorporated into the cDNA clone such that three independent cysteine mutants 301 
were constructed. When transfected, the wild type and C75S clones induced cytopathic effects 302 
and produced infectious virus with indistinguishable plaque morphology. In contrast, the C23S 303 
mutation completely abolished infectivity of the clone, indicating that C23-mediated N protein 304 
homodimerization plays a critical role in PRRSV infectivity (Lee et al., 2005). The C90S 305 
mutation also appeared to be lethal for virus infectivity. This is an unexpected observation since 306 
cysteine 90 is irrelevant to the N protein homodimerization and because cysteine 90 is absent 307 
among the EU PRRSV isolates. The EU isolates of PRRSV contain only two cysteines at 308 
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positions 27 (involved in the formation of intermolecular disulfide bonds between N proteins) 309 
and 76. The N protein dimer (Figure 1) was shown to be stable both in the presence and absence 310 
of intermolecular disulfide linkages, indicating that non-covalent interactions also play a role in 311 
dimerization. Using a series of N protein deletion mutants fused to glutathione S-transferase 312 
(GST) in a pull-down assay, aa 30 to 37 were shown to be essential for non-covalent N-N 313 
interactions (Figure 3). Furthermore, since RNase A treatment markedly decreased N protein-314 
binding affinity, it appears that at least in vitro, RNA may be involved in bridging N-N 315 
interactions. Upon translation in the cytoplasm, the N protein interacts with itself via non-316 
covalent binding. As N is transported to the lumen of the endoplasmic reticulum (ER) and the 317 
Golgi complex, where its environment is oxidative and PRRSV maturation occurs, the N–N 318 
interaction becomes disulfide linked (Snijder, Meulenberg, 1998; Wootton, Yoo, 2003). 319 
Together, these findings demonstrate that the N protein possesses self-associative properties, and 320 
these likely provide the basis for PRRSV nucleocapsid assembly.  321 
PRRSV, like several other RNA viruses, replicates in the cytoplasm (Benfield et al., 322 
1992; Mardassi et al., 1994b). However, a fraction of the N protein has been found to localize 323 
into the nucleus and nucleolus during infection of PAM and MARC-145 cells (Rowland et al., 324 
1999). Two conserved aa stretches, which are similar to sequences that resemble two classical 325 
types of nuclear localization signal (NLS), have been identified (Figure 3) in the N protein at aa 326 
positions 10 to 13 and 41 to 47 (NLS-1 or cryptic NLS and NLS-2 or functional NLS, 327 
respectively) (Rowland et al., 1999; Rowland et al., 2003). The inactivation of NLS-1 by site-328 
directed mutagenesis or the deletion of the first 14 aa did not affect N protein localization to the 329 
nucleolus. The substitution of key lysine residues with uncharged amino acids in NLS-2 blocked 330 
nuclear/nucleolar localization. Site-directed mutagenesis identified the KKNKK sequence as 331 
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forming the core localization domain within NLS-2. The NLS-2 was shown to be functional and 332 
sufficient for the translocation and accumulation of N in the nucleolus (Rowland et al., 1999; 333 
Rowland et al., 2003; Rowland, Yoo, 2003). Proteins that localize to the nucleolus typically 334 
possess a nucleolar localization signal (NoLS) motif. A region covering aa 41–72 (Figure 3) was 335 
found to contained a NoLS sequence (Rowland et al., 2003; Yoo et al., 2003). The nucleolar 336 
localization of the N protein has also been reported for EAV (Tijms et al., 2002) and for several 337 
members of the Coronaviridae (Chen et al., 2002; Wurm et al., 2001). The arterivirus and 338 
coronavirus N proteins, when expressed alone or fused to the red-shifted EGFP, localize to the 339 
nucleolus, demonstrating that translocation across the nuclear pore complex (NPC) and 340 
accumulation in the nucleolus are independent of other viral proteins (Hiscox et al., 2001; 341 
Rowland, Yoo, 2003; Tijms et al., 2002; Wurm et al., 2001). 342 
Since the Golgi apparatus is thought to be the maturation site of arteriviruses, it has been 343 
postulated that the PRRSV N protein plays dual roles during virus infection; a virion structural 344 
role in the cytoplasm and a non-structural role in the nucleus and/or nucleolus. The N protein 345 
NLS-null PRRSV-infected pigs had a significantly shorter mean duration of viremia than wild-346 
type-infected pigs and increased production of neutralizing antibodies in infected pigs (Lee et al., 347 
2006a; Lee et al., 2006b). However, MARC-145 cells infected with the NLS-null mutant virus 348 
produced cytopathology indistinguishable from that of wild-type virus, but with lower viral titers 349 
and smaller size plaques formations (Lee et al., 2006a; Lee et al., 2006b). Furthermore the N 350 
protein nuclear localization is associated with the virulence of PRRSV since modification in the 351 
NLS caused attenuation of the virus (Lee et al., 2006a; Lee et al., 2006b; Pei et al., 2008) 352 
suggesting that the N protein localization in the nucleus may play a role in viral pathogenesis. 353 
The precise mechanism of N protein trafficking within a cell and to the nucleolus is unknown, 354 
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although N protein has been shown to interact with the small nucleolar RNA (snoRNA)-355 
associated protein fibrillarin and thus may potentially localise to the nucleolus via this interaction 356 
(Yoo et al., 2003). Using an in vitro pull-down assay, the N protein was able to bind importin-α 357 
and importin-β nuclear transport proteins (Rowland, Yoo, 2003). The formation of an N 358 
protein/importin complex using in vitro translated N demonstrates that N protein binding is 359 
independent of other viral proteins. The GST-bead pull-down assay was used, to determine if the 360 
principal export shuttle protein, the chromosome region maintenance 1 (CRM1), could bind N 361 
protein (Rowland, Yoo, 2003). Radiolabeled N protein, prepared from virus infected cells or by 362 
in vitro translation, was incubated with the GST-human CRM1 fusion protein immobilized on 363 
glutathione-Sepharose beads. The results showed that CRM1 indeed bound to PRRSV N protein 364 
(Rowland, Yoo, 2003). On the opposite (Tijms et al., 2002), it was reported that EAV N protein 365 
localized to all nucleoli when cells were treated with leptomycin B (LMB), an inhibitor of 366 
CRM1-dependent export. In conclusion, the N protein nuclear transport is importin-α/β-based 367 
and CRM1-dependent. It is interesting that a virion structural protein from a cytoplasm-368 
replicating RNA virus interacts with a host cell transcription factor. It was shown previously that 369 
the PRRSV N protein can interact with fibrillarin and co-localizes with fibrillarin in the 370 
nucleolus (Yoo et al., 2003). For NA N protein, eight amino acids (IAQQNQSR) at positions 30 371 
to 37 were identified as the binding domain with fibrillarin. Interestingly, this string of aa was 372 
previously mapped as the region which participated in the formation of the N-N interaction 373 
(Wootton, Yoo, 2003). This region corresponds to a relatively hydrophilic region of N and forms 374 
part of the conformational epitope recognized by mAb SDOW17 (Wootton et al., 2001). The 375 
interaction of viral capsid with the cellular transcription factor implicates a possible regulation of 376 
host cell gene expression by the N protein during PRRSV infection (Song et al., 2009). 377 
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Localization of the virus capsid proteins and replication proteins in the nucleus and/or nucleolus 378 
appears to be an emerging feature of positive strand RNA viruses (Song et al., 2009). The reason 379 
why positive strand RNA virus capsid proteins localize in the nucleolus is unknown, and several 380 
hypotheses have been proposed including; i) as part of a cellular defense mechanism to sequester 381 
viral proteins away from sites of virus replication and assembly; ii) to recruit nucleolar proteins 382 
to facilitate virus replication; iii) to usurp cellular processes by disrupting the nucleolar 383 
proteome; or iv) only because the viral protein contains motifs which mimic nucleolar 384 
localization signals (NoLSs) (Hiscox, 2002, 2003, 2007; Rowland, Yoo, 2003; Uchil et al., 2006; 385 
Weidman et al., 2003).  386 
In resume, the N protein is the sole component of the PRRSV capsid. In addition, it is a 387 
highly immunogenic protein which makes it a suitable candidate for the detection of virus-388 
specific antibodies and subsequently for the diagnosis of the disease. The PRRSV N protein 389 
plays dual roles during virus infection; 1) a virion structural function and 2) a non-structural role 390 
in the nucleus/nucleolus, indicating that the N protein localization in these compartments may 391 
play a fundamental role in viral pathogenesis such as the regulation of cell genes expression.  In 392 
a near future, further studies will have to be conducted to elucidate the role of the N protein in 393 
the nucleus/nucleolus and will certainly give new interesting insight on the cell pathogenesis of 394 
PRRSV. 395 
  19
The membrane envelope protein (M) 396 
 397 
The M protein is an 18 to 19 kDa class III membrane protein composed of 174 and 173 398 
aa for NA and EU genotypes, respectively, and is encoded by ORF6 viral gene (Figure 2). Its 399 
membrane structure consists of a core of three successive membrane-spanning domains preceded 400 
by an ectodomain of 13–18 amino acids and followed by a C-terminal endodomain of 81–87 aa 401 
(de Vries et al., 1992; Faaberg, Plagemann, 1995; Meulenberg et al., 1995a, b). As demonstrated 402 
experimentally for the closely related M protein of coronaviruses (de Haan et al., 1998; Vennema 403 
et al., 1996), the arteriviral M protein is likely to play a key role in virus assembly and budding 404 
(Table 1). The M protein is unglycosylated and is the most conserved structural protein of 405 
arteriviruses and PRRSV (Mardassi et al., 1995a, b; Meulenberg et al., 1993b). In the virion, the 406 
GP5 and M proteins are found as a disulfide-linked heterodimer (Figure 1), which is an essential 407 
requirement for virus infectivity for arteriviruses (Delputte et al., 2002; Faaberg et al., 1995a; 408 
Mardassi et al., 1996; Snijder et al., 2003). These disulfide-linked complexes are formed in the 409 
endoplasmic reticulum (ER) of infected cells preceding or during virus assembly (de Vries et al., 410 
1995; Dobbe et al., 2001; Faaberg et al., 1995a; Mardassi et al., 1996).  411 
The GP5–M heterodimerization was shown to be essential for virus infectivity and it is a 412 
key step in the assembly of EAV virion (Snijder et al., 2003). The disulfide bond between 413 
PRRSV GP5 and M proteins presumably occurs between cysteine residues at positions 50 and 8 414 
(EU isolates), respectively (Verheije et al., 2002). Mutating either one of these residues resulted 415 
in a complete block of particle production (Verheije et al., 2002), indicating that the covalent 416 
association of GP5 and M is crucial for virus assembly. Using a reverse genetics approach it was 417 
shown that the two major envelope proteins, the GP5 and M proteins are essential for the 418 
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formation of EAV particles (Wieringa et al., 2004).  Noteworthy, it is interesting to point out that 419 
the disulfide-linked ectodomains of the LDV heterodimer VP-3P-M protein (VP-3P is the GP5 420 
homolog protein of LDV) have been proposed to stabilize the virus attachment site for 421 
interaction with a host cell receptor (Faaberg et al., 1995b).   422 
The development of neutralizing antibodies was reported in mice inoculated with a 423 
Mycobacterium bovis bacille Calmette-Guérin (BCG) expressing the M protein (Bastos et al., 424 
2002). More recently, three replication-defective recombinant adenoviruses were developed as 425 
potential vaccine against PRRSV and evaluated in a mouse model (Jiang et al., 2006a). Three 426 
groups of BALB/c mice were inoculated subcutaneously twice at 2-week intervals with the 427 
recombinants adenovirus expressing PRRSV GP5 (rAd-GP5), M (rAd-M), and M-GP5 fusion 428 
protein (rAd-M-GP5). The results showed that the mice inoculated with recombinant 429 
adenoviruses developed PRRSV-specific antibodies and a cellular immune response at 2 weeks 430 
post second inoculation (Jiang et al., 2006a). However, only mice immunized with rAd-M-GP5 431 
developed significantly higher titers of neutralizing antibodies to PRRSV and produced stronger 432 
lymphocyte proliferation responses compared to mice immunized with rAd-M or rAd-GP5 (Jiang 433 
et al., 2006a). In conclusion, the presence of M protein increases the immune response against 434 
GP5 by increasing the cellular immune response and the productions of neutralizing antibodies 435 
(Abs).  436 
Using Pepscan technology and sera of 15 experimentally NA PRRSV infected pigs, the 437 
B-cell linear epitopes were identified in some of the non-structural proteins and all of the 438 
structural proteins (de Lima et al., 2006). Overall, the highest degree of immunogenicity and 439 
conservation was exhibited by two epitopes identified in the C-terminal end of the M protein 440 
(ORF6) (de Lima et al., 2006). These immunoreactive peptides are located at position 151–174 441 
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which corresponds to the C-terminus end of the endodomain of M protein. In order to confirm 442 
the results demonstrated by the sequence alignment, the reactivity of both synthetic peptides was 443 
further tested with sera from pigs experimentally infected with several other NA PRRSV strains 444 
and all sera samples were confirmed positive. It was found that the peptide containing the 445 
residues A161VKQGVVNLVKYAK174 can be particularly useful for diagnostic purposes and one 446 
attractive candidate as a negative serological marker in a PRRSV vaccine (de Lima et al., 2006). 447 
Earlier study (Oleksiewicz et al., 2002), using phage-displayed technology, also reported the 448 
identification of one epitope localized in the large putative endodomain of the M protein (aa 449 
138–159) of a EU PRRSV strain. This epitope was recognized by sera collected very late in 450 
infection (Oleksiewicz et al., 2002).  451 
 452 
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The major glycosylated envelope viral protein (GP5) 453 
 454 
One of the most variable regions of the PRRSV genome is the ORF5 gene (Figure 2) 455 
which encodes the GP5 glycoprotein (Andreyev et al., 1997; Mardassi et al., 1995a; Meng et al., 456 
1995b). The GP5 is a transmembrane protein of approximately 25 kDa (Dea et al., 2000a; 457 
Gagnon et al., 2003; Meulenberg et al., 1995a). The GP5 protein contains an N-terminal putative 458 
signal sequence which is assumed to be cleaved (Mardassi et al., 1995a; Meng et al., 1995b; 459 
Meulenberg et al., 1995a; Murtaugh et al., 1995) of approximately 30 aa, followed by an 460 
ectodomain of approximately 35 residues with a variable number of potential N-glycosylation 461 
sites, a long hydrophobic region of about 60 residues that is presumed to span the membrane one 462 
to three times, and a hydrophilic C terminus of approximately 70 aa (Meulenberg et al., 1995a). 463 
Some authors have suggested that it possesses two membrane-spanning motifs between residues 464 
65–130 and 170–190 (Dea et al., 2000a) while others have proposed that the protein may span 465 
the membrane three times (Meulenberg, 2000). GP5 is one of the most variable (Table 1) 466 
structural protein in the PRRSV genome (Mardassi et al., 1995a; Meng et al., 1995b) with the 467 
highest degree of diversity within one genotype: 89–94% identity among NA isolates and 87.1–468 
99.25% identity among EU isolates (Andreyev et al., 1997; Suarez et al., 1996b). It is important 469 
to mention that some other parts of the genome also possess considerable degree of variability 470 
such as ORF3 gene and the nsp2 protein (Fang et al., 2004; Oleksiewicz et al., 2000). 471 
Interestingly, it was hypothesized that PRRSV exists during natural infection as a quasispecies 472 
distribution of related genotypes and that this variation could account for the inability of 473 
traditional approaches such as vaccination to control PRRS adequately. It was also found that 474 
multiple variants of PRRSV can exist simultaneously on farms and within individual animals 475 
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during natural infection (Goldberg et al., 2003). Nonetheless, the existence of quasispecies could 476 
be responsible for the emergence of viruses with novel clinical and/or antigenic properties and 477 
reduce the efficiency of vaccination.  478 
The GP5 protein of PRRSV is one of the most important structural proteins (Table 1) 479 
exposed on the surface of the virion and contains epitopes involved in virus neutralisation and 480 
protection (Ansari et al., 2006; Gonin et al., 1999; Pirzadeh, Dea, 1997, 1998; Wissink et al., 481 
2003). Monoclonal Abs (mAbs) against GP5 are able to neutralize virus infectivity in cell culture 482 
(Gonin et al., 1999; Pirzadeh, Dea, 1997; Weiland et al., 1999; Zhang et al., 1998).  In vivo, most 483 
of the neutralizing antibodies that could be found in infected animals are predominantly directed 484 
against GP5 (Gonin et al., 1999).  Pigs vaccinated with genetically engineered vaccines that 485 
express the GP5 protein could produce neutralizing antibodies against PRRSV (Jiang et al., 486 
2006b; Kheyar et al., 2005; Pirzadeh, Dea, 1998) and the pigs could be partially protected 487 
against generalized viremia and lung lesions development following PRRSV challenge 488 
(Pirzadeh, Dea, 1998; Qiu et al., 2005; Xue et al., 2004). Pregnant gilts treated with 489 
hyperimmune serum from convalescent pigs are fully protected from reproductive failure upon 490 
homologous challenge which suggests that IgG can provide a protective immunity in vivo 491 
(Osorio et al., 2002). On the other hand, other experiments have shown that GP5 antibodies alone 492 
do not provide full protection against PRRS disease even after homologous challenge (Pirzadeh, 493 
Dea, 1998; Plana-Duran et al., 1997a). Consequently, GP5 is not the only determinant of 494 
protective immunity, and is particularly unlikely to be the determinant of cross protection in case 495 
of heterologous challenge since it is highly variable.  496 
Hydropathy profiles of the GP5 protein predict that it possesses a signal sequence (aa 1–497 
32), an ectodomain (aa 33–63), a transmembrane region (aa 64–134), and an endodomain (aa 498 
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135–200), although there are some differences in the length of the predicted signal sequence 499 
between the NA and EU strains of PRRSV (Figure 4) (Andreyev et al., 1997; Dea et al., 2000a; 500 
Meng et al., 1995b; Meulenberg et al., 1995a; Stadejek et al., 2002; Yang et al., 1998). 501 
Comparison of the nt and aa sequences of the GP5 protein of a large number of PRRSV strains 502 
from NA and EU strains identified a hypervariable region (aa 32–40), two variable regions (aa 503 
57–70 and 121–130) and three conserved regions (aa 41–56, 71–120 and 131–200), and multiple 504 
potential N-glycosylation sites (Andreyev et al., 1997; Faaberg, Plagemann, 1995; Key et al., 505 
2001; Meng et al., 1995b; Plagemann, 2004; Plagemann, 1996; Stadejek et al., 2002; Yang et al., 506 
1998). The first potential N-glycosylation site is located in the hypervariable region (N32 or N33 507 
or N34) of the GP5 ectodomain, and it is present in many but certainly not all NA and EU strains 508 
of PRRSV (Figure 4). The second and third potential N-glycosylation sites are located at either 509 
aa residues N44 and N51 (NA strains of PRRSV) or N46 and N53 (EU strains of PRRSV), and 510 
are highly conserved among field strains of PRRSV. In addition to these three N-glycosylation 511 
sites some NA isolates (U.S. ATCC VR-2332 and Quebec IAF-Klop reference strains) have an 512 
additional (fourth) potential N-glycosylation site at aa residue N30 (Dea et al., 2000a; Key et al., 513 
2001; Plagemann, 2004). Using peptide mapping it was shown that the major neutralization 514 
epitope of PRRSV is located into the middle of the GP5 ectodomain (aa 36–52) (Plagemann et 515 
al., 2002). Using swine polyclonal antisera and mouse mAbs, the non-neutralizing (epitope A) 516 
and neutralizing epitopes (epitope B) in the ectodomain of the GP5 protein of PRRSV were 517 
identified (Ostrowski et al., 2002). Epitope B was recognized by a neutralizing mAb and high 518 
SN-titered swine antisera. Neutralizing epitope B includes aa 37–45 of GP5 and is conserved 519 
among PRRSV isolates, but it is not immunodominant (Figure 4). In contrast, the non-520 
neutralizing epitope A includes aa residues 27–30, and is hypervarible and immunodominant 521 
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(Figure 4). Interestingly, PRRSV-infected pigs first develop antibodies against epitope A and 522 
neutralizing antibodies against epitope B only appear later. Thus, the immunodominant epitope 523 
A may act as a decoy and so delay the neutralizing antibody response against epitope B, although 524 
the true significance of this potential mechanism of immune evasion of field strains of PRRSV 525 
remains uncertain (Plagemann, 2004). The presence of N-glycans in and around epitope B may 526 
also reduce the immunogenicity of this critical neutralization determinant in the GP5 protein, 527 
consistent with the low immunogenicity of PRRSV virions into mice and their failure to develop 528 
a strong neutralizing antibody response to the virus. Using the site-directed mutagenesis and 529 
pepscan analysis it was shown that the aa residue at position 24 of the GP5 signal sequence of an 530 
EU strain of PRRSV was critical for a neutralizing mAb recognition; specifically, the presence 531 
of a proline residue at position 24 promotes cleavage of the signal peptide at residues 28 and 29 532 
rather than 32 and 33 (Wissink et al., 2003). They also demonstrated a second neutralization 533 
epitope recognized by mAbs that includes aa 29–35 of GP5. Together these data suggest that the 534 
major neutralization determinants of PRRSV are located in the N-terminal portion of the GP5 535 
protein, and that inherent properties of the protein such as “decoy” epitopes and heterogeneous 536 
glycosylation that obscures the critical neutralization site(s) can impede and decrease the 537 
humoral immune response against PRRSV GP5. 538 
Several studies provide evidence that glycosylation of GP5 of PRRSV play an important 539 
role in escaping or minimizing virus-neutralizing antibody response by a N-glycan-shielding 540 
mechanism (Johnson et al., 2003; Wei et al., 2003). This N-glycan neutralisation shielding 541 
mechanism is also observed in LDV (Chen et al., 2000) and others viruses such as hepatitis B 542 
virus (HBV) (Lee et al., 2003), simian immuno deficiency virus (Reitter, Desrosiers, 1998), 543 
Influenza virus (Skehel et al., 1984), and human immuno deficiency virus (HIV) (Wei et al., 544 
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2003). Biochemical studies indicate that the mature GP5 contains high-mannose-type sugar 545 
moieties at all three N-glycosylation sites (N34, N44, and N51) (Figure 4). The mutation 546 
involving residue N44 did not result in infectious progeny production, indicating that N44 is the 547 
most critical aa residue for infectivity. Viruses carrying mutations at N34, N51, and N34/51 grew 548 
to lower titers than the wild-type (wt) PRRSV (Ansari et al., 2006). All mutated viruses exhibited 549 
enhanced sensitivity to neutralization by swine sera. Furthermore, inoculation of pigs with the 550 
mutant viruses induced significantly higher levels of neutralizing antibodies against the mutants 551 
as well as the wt PRRSV, suggesting that the loss of N-glycan residues in the ectodomain of GP5 552 
enhances both the sensitivity of these viruses to in vitro neutralization and the immunogenicity of 553 
the nearby neutralization epitope (Ansari et al., 2006). Similar results have been obtained in 554 
regards to GP5 of the EU reference strain LV and demonstrate that the N-glycan moitie of the 555 
N46 glycosylation site (which corresponds to the N44 in the case of NA strains) is required for 556 
virus particle production (Wissink et al., 2004). Interestingly, the authors also found that the N-557 
linked glycans normally located at the N53 of GP5 (which corresponds to the N51 for NA 558 
strains) and present on the GP2a protein are not essential for particle formation. Furthermore, the 559 
lack of N-linked oligosaccharides on GP2a and at N53 of GP5 did not significantly affect the 560 
infectivity of the viruses compared to GP5 N46 mutant (Wissink et al., 2004). In conclusion, 561 
preventing the glycosylation of the GP5 protein at position N44 and N46, respectively for NA 562 
and EU strains, had dramatic effects on virion production and virus infectivity (Wissink et al., 563 
2004). The N-linked glycosylation, in general, is important for correct folding, targeting, and 564 
biological activity of proteins (Helenius, 1994; Helenius, Aebi, 2001, 2004). In many enveloped 565 
viruses, the envelope proteins are modified by the addition of sugar moieties and the N-linked 566 
glycosylation of envelope protein plays diverse functions such as receptor binding, membrane 567 
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fusion, penetration into cells, and virus budding (Braakman, van Anken, 2000; Doms et al., 568 
1993). Furthermore, it has become evident that glycosylation of viral envelope proteins is a 569 
major mechanism for viral immune evasion and virus persistence which has been used by several 570 
different enveloped viruses to escape, block, or minimize the virus-neutralizing antibody 571 
response. Examples of this effect have now been reported for PRRSV and several other viruses 572 
such as arterivirus LDV (Chen et al., 2000), simian immunodeficiency virus (Reitter, Desrosiers, 573 
1998), hepatitis B virus (Lee et al., 2003) influenza virus (Skehel et al., 1984).   574 
GP5 forms an heterodimeric complex with the M protein (Figure 1) via disulfide bound 575 
(Mardassi et al., 1996; Snijder et al., 2003). The disulphide bond between GP5 and M occurs 576 
between Cys50 and Cys8 (EU isolates) of the respective proteins (Verheije et al., 2002). 577 
Mutating either one of these residues resulted in a complete block of particle production 578 
(Verheije et al., 2002), indicating that the covalent association of GP5 and M is crucial for virus 579 
assembly (Verheije et al., 2002). The PRRSV GP5–M complexes were shown to interact with 580 
heparin (Delputte et al., 2002), suggesting a role in regards to attachment of virus to alveolar 581 
macrophages. Thereafter, it has been proposed that the GP5 is involved in the entry of virus into 582 
the host cells, presumably by interacting with the macrophages host cell receptor sialoadhesin 583 
(Delputte, Nauwynck, 2004). The role of GP5 in receptor recognition is supported by the 584 
presence of a major neutralization epitope in the N-terminal ectodomain (Ostrowski et al., 2002), 585 
implying a central role for the GP5 ectodomain in the infection process. 586 
The GP5 protein is involved in the apoptosis phenomenon induce by PRRSV (Gagnon et 587 
al., 2003; Suarez et al., 1996a). The apoptotic inducing region of GP5 has been mapped to the 588 
first N-terminal 119 aa  (Fernandez et al., 2002). During apoptosis in PRRSV infected MARC-589 
145 cells and in MARC-145 cells expressing the GP5 protein, specific apoptotic enzymes, are 590 
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activated, like caspase-3 which is a hallmark of apoptosis pathways induction (Gagnon et al., 591 
2003).  592 
The MARC-145 and HeLa cells were transfected with ORF4 and ORF5 of PRRSV and 593 
differential gene expressions were studied using microarray chips embedded with 1718 human-594 
expressed sequence tags (Lee et al., 2004). Genes associated to protein degradation, protein 595 
synthesis and transport, and various other biochemical pathways were found to be regulated. In 596 
GP5-expressing HeLa cells, actin-related protein 1 (ARP1) homologs A and B were identified to 597 
be up-regulated (Lee et al., 2004). These genes encode a subunit of dynactin that binds to both 598 
microtubules and cytoplasmic dynein, and is involved in ER-to-Golgi transport (Lees-Miller et 599 
al., 1992). Then it is possible that the GP5 may play a role in the intracellular transport of viral 600 
and cellular components. The bisphosphoglycerate mutase (BPGM) gene was down-regulated by 601 
GP5 by more than six-folds (Lee et al., 2004). In humans, deficiency of BPGM has been shown 602 
to be associated with anemia (Jacobasch, Rapoport, 1996). RASSF2 was also down-regulated by 603 
GP5. RASSF2 is a new member of the RASSF1 family and shares the properties of Ras 604 
effector/tumor suppressors (Vos et al., 2003). Similarly, cyclin D3 gene expression was found to 605 
be suppressed. D-type cyclins are the key regulators along with cyclin E for cell cycle 606 
progression from G1 to S phase. Complexes formed between cyclin D or cyclin E and their 607 
kinase partners are involved in phosphorylation of retinoblastoma protein, which ultimately leads 608 
to activation of E2F transcription factor and progression to S phase of the cell cycle. Other study 609 
demonstrates a clear reduction of cyclin D3 and cell cycle arrest in G0/G1 phase in cells infected 610 
with mouse hepatitis coronavirus, a member of the nidoviruses (Chen, Makino, 2004). In 611 
addition, a consistent increase in the expression of cathepsin genes was observed in GP5 612 
expressing cells (Lee et al., 2004). Cathepsin is involved in protein degradation. Despite the fact 613 
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that a specific role of cathepsin during virus replication remains to be determined, the up-614 
regulation of genes encoding proteases may represent a cellular defence against expression of 615 
foreign proteins.  616 
In resume, the GP5 protein is one of the most variable proteins of PRRSV and is an 617 
important virus structural protein exposed on the surface of the virion that is involved in 1) cells 618 
death by apoptosis, 2) cells recognition and binding, 3) antibodies-dependent virus neutralisation 619 
and 4) immune protection in immunized or infected animals. Noteworthy, GP5 is not the only 620 
determinant of a protective immunity and is particularly unlikely to be an important determinant 621 
in regards to the cross protection immunity which is needed because of the broad spectrum of 622 
PRRSV strains heterogeneity. The N-glycosylation of GP5 decreases significantly the 623 
immunogenicity of the nearby enclosed neutralizing epitope and provides a way to evade the 624 
neutralizing antibody immune response. Other viral epitopes, which are able to induce 625 
neutralizing antibodies but with a significantly lesser extent compared to GP5, appear to reside 626 
on the other PRRSV proteins like M, GP2a, GP3, and GP4. GP5 immunized animals develop a 627 
partial protective immune response. GP5 fusion proteins (such as M-GP5 and GP3–GP5, GP4–628 
GP5, or GP3–GP4–GP5) are able to increase the protective immune response in vaccinated 629 
animals compared to GP5 alone. Thus, it is easy to conclude that for vaccine development, GP5 630 
should be optimized in its ability to induce neutralizing antibodies by allowing its fusion with 631 
other viral proteins or by reducing its N-glycosylation state. Nonetheless, all data suggest that 632 
other viral proteins should be further investigated, such as the nsp proteins (see the nsp proteins 633 
section bellow), if we hope to develop an efficient method to increase significantly the protection 634 
of swine against PRRSV infection. 635 
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Minor PRRSV structural proteins 636 
 637 
Three N-glycosylated minor envelope proteins (GP2a, GP3, and GP4) are translated from 638 
ORF2a, 3, and 4 and are found in virions as an heterotrimers form by disulfide linkage (Figure 1 639 
and 2) (Wissink et al., 2005). The ORF2b gene, which is completely embedded in ORF2a, 640 
encodes another non-glycosylated minor protein named E protein (Figure 2) (Wu et al., 2001).  641 
The ORF2 gene (Figure 2) encodes two minor structural proteins (GP2a and E) (Snijder et 642 
al., 1999). It was shown that NA PRRSV ORF2 contains a small 219 nt ‘‘ORF2b’’ gene and its 643 
translation is initiated five nucleotides downstream of the initiation codon of the large ORF2, 644 
now named ‘‘ORF2a’’. Using a baculovirus expression construct, it was shown that the full-645 
length ORF2 gene expressed both GP2a and E in insect cells and that ORF2b is in a better context 646 
for translation and may be preferentially expressed compared to ORF2a (Wu et al., 2001).  647 
 648 
The minor glycosylated envelope viral protein GP2a 649 
 650 
The 29 to 30 kDa GP2a is a putative class I integral membrane protein with an N-terminal 651 
signal sequence and a C-terminal membrane anchor domain (Meulenberg et al., 1995a). The 652 
GP2a of the NA and EU strains possesses (Table 1) 256 and 249 aa, respectively (Meulenberg et 653 
al., 1995a). The GP2a of EU and NA strains of PRRSV contain 2 distinctive hydrophobic peaks 654 
and share two highly conserved putative N-linked glycosylation sites (Meng et al., 1995b; 655 
Meulenberg et al., 1995a; Meulenberg et al., 1997; Morozov et al., 1995; Wissink et al., 2004). 656 
The significance of the N-glycosylation of the GP2a protein for virus production and viral 657 
infectivity has been investigated in regards to the EU LV strain (Wissink et al., 2004). After 658 
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analysing the GP2a protein of virus mutants, the results showed that the GP2a N-linked glycans 659 
are not essential for virus particle formation (Wissink et al., 2004). The antigenicity of the GP2a 660 
is largely unexplored and there is no data in regards to the NA strains. Two GP2a linear epitopes 661 
were found to be immunoreactive with 60% (9/15) of swine sera (de Lima et al., 2006). The 662 
reactive peptides comprise regions at aa positions 41–55 and 121–135. Using phage-displayed 663 
peptides, three weakly antigenic B-cell epitopes were identified in the GP2a at positions 36–51, 664 
117–139 and 120–142 (Oleksiewicz et al., 2002). When ORF2 and ORF4 genes (which encode 665 
for minor structural glycoproteins GP2a/E and GP4, respectively) were individually deleted from 666 
the viral genome of a NA strain, both PRRSV deletion mutants were non-viable in MARC-145 667 
cells and PAM, indicating that both genes are essential for virus replication (Welch et al., 2004). 668 
 669 
The minor non-glycosylated envelope viral protein E 670 
 671 
The E protein is an unglycosylated small hydrophobic protein which is membrane-672 
associated and believed to be present in all arteriviruses (Snijder et al., 1999; Wu et al., 2001). 673 
The PRRSV E protein, is translated from the internal ORF2b starting from the +6 nucleotide 674 
position in mRNA2 (Figure 2) (Snijder et al., 1999). The E protein of the NA and EU strains 675 
possesses (Table 1) 73 and 70 aa, respectively (Wu et al., 2001). The E protein is a small 10 kDa 676 
protein with a central hydrophobic domain, and an hydrophilic C terminus containing a cluster of 677 
basic residues (Snijder et al., 1999). In addition, the E protein possesses a potential N-terminal 678 
N-myristoylation site and a potential casein kinase II phosphorylation site (Snijder et al., 1999). 679 
The E protein of PRRSV has been identified to be incorporated into the envelope virion structure 680 
such as its EAV homologous protein (Wu et al., 2005) (Figure 1). 681 
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Besides its structural function, the E protein function is currently unknown. Reverse 682 
genetics, using an infectious EAV clone, demonstrated that the E protein is required for the 683 
production of infectious virions (Snijder et al., 1999). It was shown that a covalent association of 684 
the E protein with the GP2b-GP3-GP4 heterotrimers exists in EAV, suggesting a possible role of 685 
the heteromultimeric complex in the virus entry process. The absence of the E protein entirely 686 
prevented the incorporation of the GP2b-GP3-GP4 proteins into viral particles (Wieringa et al., 687 
2004). Several studies using a EU PRRSV isolate showed that the E protein is incorporated into 688 
the virions and associated covalently with GP2a–GP3–GP4 heterotrimers (Figure 1), suggesting a 689 
critical role for the heteromultimeric complex (Wissink et al., 2005). The PRRSV E protein 690 
possesses two cysteines at positions 49 and 54 that are highly conserved among NA isolates. The 691 
importance of the cysteine residues of the E protein was determined using a NA PRRSV 692 
infectious cDNA clone. Each cysteine was substituted by a serine. When the mutated PRRSV 693 
infectious cDNA clone were transfected into MARC-145 cells, all cysteine mutant clones 694 
induced PRRSV-specific cytopathic effects and produced infectious progeny virus. The data 695 
indicates that cysteine residues in the E protein are not essential for PRRSV replication (Lee, 696 
Yoo, 2005). In addition, the results obtained show that the N and E proteins of PRRSV do not 697 
form cysteine-linked covalent linkages but that they do form cysteine-independent non-covalent 698 
associations (Lee, Yoo, 2005). Therefore, the authors postulated that the interaction between N 699 
and E may be initiated following the binding of viral RNA to the N protein (Yoo et al., 2003). 700 
Subsequently, the N–RNA interaction may promote the N protein association with E, providing 701 
stable assembly of the core structure in the virion. Noteworthy, the cysteines of E protein are not 702 
well conserved among arteriviruses (Snijder et al., 1999). In comparison to PRRSV NA strains, 703 
the EU strains contain only a single cysteine at position 51, while E proteins of LDV, EAV and 704 
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SHFV contain a single cysteine residue at different positions (Snijder et al., 1999). Interestingly, 705 
it was found that a single NA PRRSV mutation at arginine 51 in the basic region of E is lethal 706 
for PRRSV, supporting the premise that the N–E non-covalent interaction may be a requirement 707 
for PRRSV replication (Lee, Yoo, 2005). On the other hand, an infectious cDNA clone was used 708 
to generate an E gene-knockout PRRSV mutant, and this study report that the E protein is 709 
essential for virus infectivity but dispensable for virus particle formation (Lee, Yoo, 2006). The 710 
E deleted non-infectious virus particles were able to enter cells but unable to continue  further 711 
steps of replication (Lee, Yoo, 2006). It is therefore tempting to speculate that PRRSV may 712 
contain a viral ion channel protein to promote the uncoating process in the endosome during the 713 
early stage of infection. Furthermore, two ion channel blockers were shown to greatly affect 714 
PRRSV replication at early stages of infection, suggesting that ion channel activity was essential 715 
for virus uncoating (Lee, Yoo, 2006). In addition it was found that expression of the E protein 716 
enhances membrane permeability of hygromycin B in bacterial cells. Interestingly, the 717 
coronavirus E protein has been shown to modify membrane permeability (Liao et al., 2004; 718 
Madan et al., 2005) as well as to form cation-selective ion channels in an artificial membrane 719 
(Wilson et al., 2004). Results obtained in a previous study support the hypothesis that the 720 
PRRSV E protein may function as an ion channel for virus uncoating (Lee, Yoo, 2006). 721 
Recently, the E protein myristoylation was explored using the reverse genetics approach 722 
(Du et al., 2010). The E protein contains the consensus 1MGxxxS6 motif for its myristoylation, 723 
and in the presence of 2-hydroxymyristic acid, the virus TCID50 titer decreased by 2.5 log10 and 724 
the level of viral RNA was reduced significantly. Thus, the E protein myristoylation is non-725 
essential for PRRSV infectivity but promotes the growth of the virus (Du et al., 2010). 726 
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The minor glycosylated envelope viral protein GP3 727 
 728 
The GP3 protein is encoded by the ORF3 (Figure 2) gene and is one of the most variable 729 
PRRSV proteins, showing approximately 54 to 60% aa identity between the NA and EU 730 
genotypes (Dea et al., 2000a). The GP3 is comprised (Table 1) of 254 and 265 aa for NA and EU 731 
isolates, respectively (Mardassi et al., 1995a; Meng et al., 1995b; Meulenberg et al., 1995a; 732 
Murtaugh et al., 1995). Several studies have reported that the most variable region of GP3 is 733 
located at the first 35 aa, which is 29% identical among EU and NA isolates (Katz et al., 1995; 734 
Mardassi et al., 1995a; Murtaugh et al., 1995). The 45 to 50 kDa molecular weight GP3 protein is 735 
highly glycosylated (Table 1) and possesses seven potential N-linked oligosaccharides and has a 736 
single N terminal hydrophobic domain (Meulenberg et al., 1995a). The glycosylation sites are 737 
highly conserved among NA and EU PRRSV stains (Gonin et al., 1998; Mardassi et al., 1995a; 738 
Meulenberg et al., 1995a; Wissink et al., 2004). The GP3 protein seems to take a special position 739 
among the arterivirus glycoproteins. Since its membrane topology has not been resolved and 740 
seems to be strain dependent (Hedges et al., 1999; Mardassi et al., 1998; Wieringa et al., 2002), 741 
its virion structural nature is also controversial (Figure 1). For LDV, the GP3 protein was 742 
reported to be a non-structural, soluble glycoprotein that is secreted from infected cells (Faaberg, 743 
Plagemann, 1997). In contrast, the GP3 protein of EAV was clearly demonstrated to be 744 
incorporated into virions (Wieringa et al., 2002). For PRRSV, both situations have been 745 
described (de Lima et al., 2009; Gonin et al., 1998; Mardassi et al., 1998; Meulenberg et al., 746 
1995a; van Nieuwstadt et al., 1996; Wissink et al., 2005). Thus, the GP3 protein of the prototype 747 
EU LV strain was found to be incorporated into virions (Meulenberg et al., 1995a; van 748 
Nieuwstadt et al., 1996) and membrane-associated as heterotrimers with GP2a and GP4 (Wissink 749 
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et al., 2005). However, the GP3 protein of the IAF-Klop reference strain (a typical NA isolate) 750 
was found to be non-structural and secreted from PRRSV infected cells (Gonin et al., 1998; 751 
Mardassi et al., 1998). This dual nature of GP3 is a reminiscence of viral glycoproteins which 752 
could be found in several other viruses such as the glycoproteins G (gG) of alphaherpesviruses 753 
(Bryant et al., 2003; Murata et al., 2002) and the Erns glycoprotein of bovine viral diarrhea virus 754 
(BVDV) (Iqbal et al., 2004). The gG protein of alphaherpesviruses is found in the virus envelope 755 
and, in some alphaherpesviruses, is also secreted after proteolytic processing. In addition, these 756 
secreted forms of gG were reported to have chemokine binding activity, thereby inhibiting the 757 
biological activity of these chemokines in vitro (Bryant et al., 2003). The BVDV Erns protein, in 758 
addition to being a virion protein, is also secreted from infected cells into the extracellular 759 
environment. This secreted form was recently shown to block the double-stranded RNA 760 
interferon-inducing signal (Iqbal et al., 2004).  761 
According to several reports, GP3 is highly antigenic (Faaberg, Plagemann, 1997; Gonin 762 
et al., 1998; Hedges et al., 1999; Katz et al., 1995). Although the GP3 antibody is present at a 763 
very low level in pigs, it reportedly plays a role in clearing the viral infection (Plana Duran et al., 764 
1997b) and may be involved in viral neutralization along with the GP5 and M proteins (Cancel-765 
Tirado et al., 2004). Using a phage display library, two epitopes spanning aa regions 60–85 and 766 
243–250 of a EU GP3 protein were identified (Oleksiewicz et al., 2002; Oleksiewicz et al., 767 
2001b). Two other GP3 epitopes of a NA strain were found and located at aa 73–87 and 66–81 768 
(Zhou et al., 2006). Further analyses revealed that the two epitopes are not conserved among all 769 
NA-type isolates. After analyzing the degree of antigenic variability in a series of EU isolates 770 
using monoclonal antibodies, it was determined that the C-terminus antigenicity of GP3 varied a 771 
lot among the different EU isolates (Drew et al., 1995). Two replication-defective recombinant 772 
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adenoviruses expressing GP3 (rAd-GP3) or truncated GP3 (rAd-tGP3, a hydrophobic region of aa 773 
2–64 was deleted) were constructed and their immunogenicity was tested in mice (Jiang et al., 774 
2007). The results showed that the mice immunized with recombinant adenoviruses developed 775 
PRRSV-specific neutralizing antibodies and cellular immune response, including T-cell 776 
proliferation responses and cytotoxic T-cell responses, by 2 weeks post-primary immunization. 777 
Moreover, the levels of immune responses of mice immunized with rAd-tGP3 were significantly 778 
higher than that of mice with rAd-GP3.  779 
 780 
The minor glycosylated envelope viral protein GP4 781 
 782 
The 31 to 35 kDa molecular weight GP4 protein is a putative class I integral membrane 783 
protein with an N-terminal signal sequence and a C-terminal membrane anchor (Meulenberg et 784 
al., 1995a). The GP4 protein is highly glycosylated during transport through the ER–Golgi 785 
complex (van Nieuwstadt et al., 1996). Four putative N-linked glycosylation sites which are 786 
conserved among the NA and EU PRRSV strains are found within the protein (Meulenberg et 787 
al., 1995a; van Nieuwstadt et al., 1996; Wissink et al., 2004). The aa sequence shows that GP4 788 
contains a putative N-terminal signal sequence at positions 1–22, and an additional hydrophobic 789 
sequence at positions 162–178 at the C-terminus. The GP4 protein is a minor structural protein 790 
consisting of 178 and 183 aa (Table 1) for NA and EU strains, respectively (Murtaugh et al., 791 
1995) and like GP5, is also able to induce neutralizing antibodies with lesser extent (Meulenberg 792 
et al., 1997; Weiland et al., 1999). The GP4 protein of LV possesses neutralizing epitopes which 793 
are not conserved among NA and EU strains (Meulenberg et al., 1997; Weiland et al., 1999). The 794 
neutralizing domain of the GP4 of the LV strain has been mapped to a hydrophilic exposed 795 
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region, adjacent to its N-terminal region (aa position 40–79) which appears to be highly variable 796 
among the EU strains (Meulenberg et al., 1997; Weiland et al., 1999). Approximately 65% of 797 
PRRSV-positive sera obtained from affected pig farms in the US and Canada react positively by 798 
immunoblotting against the E. coli-expressed recombinant ORF4 protein (Gonin et al., 1999; 799 
Kwang et al., 1994). However, no correlation has been demonstrated between virus 800 
neutralization titers of convalescent pig sera and the presence of anti-GP4 antibodies (Gonin et 801 
al., 1999). Using Pepscan technology Lima et al. (2006) detected the B-cell linear epitope in NA 802 
GP4 (aa 51-65) and using phage display libraries Oleksiewicz et al. (2001 and 2005) detected a 803 
single linear epitope in EU GP4 (aa 59-71).  804 
Transfection of PRRSV permissive cells with an ORF4 deleted infectious cDNA clone 805 
revealed that the ORF4 gene is essential for virus replication (Welch et al., 2004). The 806 
experiments conducted by Lee and collaborators (Lee et al., 2004) demonstrated that like GP5, 807 
the GP4 is able to alter cellular mRNA synthesis. In cell expressing GP4, the majority of 808 
differentially expressed genes were involved in synthesis, transport, and biochemical pathways 809 
(Lee et al., 2004). This observation implicates that the GP4 protein may utilize or change host 810 
cell machinery to transport viral or cellular components to the cell surface.  811 
 812 
 813 
In resume, the minor structural proteins are essential for virus infectivity and they are 814 
incorporated into virions as a multimeric complex. Recently they became the point of interest of 815 
several PRRSV investigators. Therefore, new interesting findings in regards to the function of 816 
the minor viral structural proteins should be expected. The minor structural proteins multimeric 817 
complex was shown to interact with the cell receptor CD163 with or without the involvement of 818 
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M-GP5 heterodimers. Thus, this latest finding could lead us to formulate new important 819 
questions such as: 1) can minor structural proteins multimeric complex target the virus to a 820 
certain cell type and organ?; or 2) is the multimeric complex involved in the receptor-mediated 821 
endocytosis virus entry? Other questions could certainly be formulated.  Nonetheless, new 822 
investigations in regards to the minor structural proteins will certainly help to increase our 823 
understanding of PRRSV cell pathogenesis. 824 
 825 
 826 
Viral structural proteins interactions 827 
 828 
While the major viral structural proteins are essential for particle formation, the minor 829 
viral structural proteins are essential for virus infectivity (Wissink et al., 2005). Furthermore, the 830 
minor structural proteins are incorporated into virions as a multimeric complex (Figure 1). 831 
Interestingly, the absences of any of the four proteins appear to affect the incorporation of all 832 
three others. Thus, no GP3 was detected in viral particles when the expression of either GP2a, or 833 
E, or GP4 was prevented, and no detectable GP4 was incorporated in the absence of GP2a, E, and 834 
GP3. Similar observations were made with EAV (Wieringa et al., 2004). From these results, three 835 
main conclusions could be draw. First of all, each of the membrane viral proteins is essential for 836 
the production of infectious virus. Second, the GP5 and M protein are both crucial for particle 837 
formation, consistent with a role as the fundamental building blocks of the viral envelope. Third, 838 
while not required for particle assembly, the minor glycoproteins GP2a, GP3, and GP4, and 839 
probably also the minor envelope protein E, interact with each other. This interaction is likely to 840 
be of critical importance for their incorporation as heteromultimeric complexes into PRRSV 841 
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particles and essential for rendering these particles infectious (Wissink et al., 2005).  842 
Noteworthy, the contradictory report in regards to the presence or the absence of GP3 in viral 843 
particles seems to be a strain dependant phenomenon and its absence does not seem to abolish 844 
the formation of infectious viruses (Wissink et al., 2005).  Recently, a strong interaction was 845 
found between GP4 and GP5 proteins, although weak interactions among the other minor 846 
envelope glycoproteins and GP5 have been detected (Das et al., 2010). Both GP2a and GP4 847 
proteins were found to interact with all the other viral glycoproteins resulting in the formation of 848 
multiprotein complex. In addition, it was found that the multimeric complexes of the minor 849 
glycoproteins, with or without the M and GP5 proteins, are involved in direct interaction with the 850 
cell surface receptor (Das et al., 2010). It appears that the GP4 is a critical viral envelope protein 851 
that not only mediates interactions with other viral envelope glycoproteins, but also along with 852 
GP2a, mediates interactions with the CD163 for virus entry. More specifically, it was show that 853 
only the GP2a and GP4 proteins interact with CD163. Since the minor envelope proteins are not 854 
required for particle formation (Wissink et al., 2005) and there are only few large multimeric 855 
glycoprotein complexes present on the virion envelope (Spilman et al., 2009), these results 856 
suggest that the major function of the minor glycoprotein complex on the virion envelope is to 857 
interact specifically with the cell surface receptor for virus entry (Das et al., 2010). 858 
Several research groups have been involved in the study of the immune response 859 
triggered by each of the major structural proteins (GP5 and M) of PRRSV (Bastos et al., 2002; 860 
Bastos et al., 2004; Jiang et al., 2006b; Pirzadeh, Dea, 1998; Plana-Duran et al., 1997a, b; Qiu et 861 
al., 2005) but only few information is yet available on the characterization of the minor structural 862 
proteins, such as GP3 and GP4. A recent study (Jiang et al., 2008) reports the tandem cloning and 863 
expression of two or three proteins of PRRSV, the GP3, GP4, or GP5, in replication-defective 864 
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human adenovirus type 5 (Ad5) vectors. Mice inoculated with the recombinant Ad5 expressing 865 
the GP3–GP5, GP4–GP5, or GP3–GP4–GP5 of PRRSV developed a specific immune response 866 
against the viral proteins, and this response was significantly increased against GP5 when GP3 867 
and/or GP4 were present in the adenovirus vector compared to GP5 alone (Jiang et al., 2008). 868 
These results indicated that fusion expression GP3 and/or GP4 with GP5 may be an alternative 869 
strategy to design more effective vaccines. 870 
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Non-structural PRRSV proteins 871 
 872 
RNA synthesis of the positive-stranded RNA viruses that belong to the order Nidovirales 873 
involves the replication of the genome-length RNA (RNA1) and the synthesis of subgenomic 874 
mRNAs (sg mRNAs). Both processes are mediated by a ‘replication/transcription complex’ 875 
(RTC) composed of virus-encoded non-structural proteins (nsp) and presumably also host factors 876 
(Gorbalenya et al., 2006). Following virus entry and release of the genome into the cytoplasm, 877 
the nidovirus life cycle starts with the expression of the large replicase gene that consists of 878 
ORF1a and ORF1b (Figure 2). The replicase-associated genes, ORF1a and ORF1b, are located 879 
on the 5’ end of the genome (representing almost 75% of the viral genome) and encode for the 880 
polyproteins pp1a and pp1ab (Figure 2). The pp1a is encoded by ORF1a, and the synthesis of 881 
pp1ab occurs through a ribosomal frame shift at the ORF1a-1b junction (Brierley, 1995; Snijder, 882 
Meulenberg, 1998). The pp1a is predicted to be cleaved at eight (Figure 2) sites to form nine nsp: 883 
nsp1α, nsp1β, and nsp2 to nsp8 (den Boon et al., 1995; Snijder, Meulenberg, 1998). Proteolytic 884 
cleavage of the ORF1b gene portion of the pp1ab generates (Figure 2) products nsp9 through 885 
nsp12 (van Dinten, 1996). The products derived from pp1a possess proteolytic activities (Table 886 
1) and are responsible for processing the other nsp cleavage products; whereas nsp9 to nsp12 are 887 
involved in virus transcription and replication (Snijder, Meulenberg, 1998; van Dinten, 1996). 888 
These polyproteins are immediately translated upon virus entry and then proteolytically 889 
processed by viral encoded proteinases into intermediate precursors and at least 12 mature nsp, 890 
which appear to be responsible for forming membrane-bound replication complexes, called 891 
virus-induced double-membrane vesicles and which are sites for viral RNA synthesis (Snijder, 892 
Meulenberg, 1998). The processing of pp1a and pp1ab is believed to be mediated by accessory 893 
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proteinases (Figure 2), located in nsp1 and nsp2, and the main serine proteinase located in nsp4, 894 
the 3C-like proteinase (3CLpro) (Ziebuhr et al., 2000). The catalytic sites of these enzymes and 895 
the corresponding cleavage sites of pp1a are well conserved among arteriviruses (Ziebuhr et al., 896 
2000). Processing of pp1a in PRRSV begins with the N-terminal nsp1, which is automatically 897 
cleaved by papain-like cysteine proteases (PCPα and PCPβ) which are contained in nsp1 (Figure 898 
2) (Kroese et al., 2008), while the PCPα domain is inactive in EAV (den Boon et al., 1995; 899 
Snijder et al., 1993). Arterivirus nsp2 contains a predicted cysteine proteinase (PL2pro) in its N 900 
terminus (Figure 2) that was shown to cleave the pp1a at the nsp2-nsp3 junction in EAV (Snijder 901 
et al., 1995b; Snijder, 1998). The 3CLpro (Figure 2) is responsible for processing the remainder 902 
of ORF1a and ORF1ab into several subunits (nsp3 to 12) (van Dinten et al., 1999; Ziebuhr et al., 903 
2000).  904 
The non-structural polypeptides encoded in Nidovirales ORF1b regions have been 905 
predicted to have essential roles (Table 1) in virus replication and gene expression (Allende et 906 
al., 1999; Gorbalenya, 1989; Meulenberg et al., 1993a; Nelsen et al., 1999; van Dinten, 1996). 907 
Evidence for the significant role of these proteins in arteriviruses has been derived using an 908 
infectious clone of EAV (van Dinten et al., 1997; van Dinten et al., 1999; van Dinten, 2000; van 909 
Marle et al., 1999).  Putative RNA-dependent RNA polymerase and NTPase/RNA helicase 910 
motifs are associated with nsp9 and nsp10, respectively. The nsp10 also contains a putative zinc 911 
finger region, which is implicated in subgenomic mRNA synthesis and genome replication. 912 
Thus, it can be assumed that the reduction of ORF1ab transcripts and nsp10 expression might 913 
affect negatively expression of the other viral proteins. The nsp11 contains a region with 914 
unknown function, but is conserved in all nidoviruses which suggests a crucial role for this viral 915 
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protein (den Boon et al., 1991; Godeny et al., 1993; Gorbalenya, 1989; Meulenberg et al., 1993a; 916 
van Dinten, 1996). 917 
The nsp1 is a multifunctional protein (Table 1) containing two papain-like cysteine 918 
proteases and a zinc-finger motif required for sg mRNA transcription (den Boon et al., 1995; 919 
Kroese et al., 2008; Oleksiewicz et al., 2004; Tijms, Snijder, 2003; Tijms et al., 2001). 920 
Intracellular concentrations of nsp1 may be higher than other nsp, due to translation from 921 
heteroclite RNAs (Yuan et al., 2000; Yuan et al., 2004). Its papain-like autoprotease domain 922 
releases nsp1 from the replicase polyproteins, a  cleavage essential for viral RNA synthesis. 923 
Several mutations in the putative N-terminal zinc finger domain of nsp1 selectively abolished 924 
transcription, while replication was either not affected or even increased. Other nsp1 mutations 925 
did not significantly affect either replication or transcription but still dramatically reduced the 926 
production of infectious progeny. Thus, nsp1 is involved in at least three consecutive key 927 
processes in the EAV life cycle: ORF1ab polyprotein processing, transcription, and virion 928 
biogenesis (Tijms et al., 2007). Both N-terminal cleavage products of nsp1, the nsp1α and the 929 
nsp1β, of the replicase polyproteins of PRRSV contain a papain-like autoproteinase domain, 930 
which have been named PCPα and PCPβ, respectively. To assess their role in the PRRSV life 931 
cycle, substitutions and deletions of the presumed catalytic cysteine and histidine residues of 932 
PCPα and PCPβ were made into a PRRSV infectious cDNA clone. Mutations that inactivated 933 
PCPα activity completely blocked sg mRNA synthesis, but did not affect genome replication. In 934 
contrast, mutants in which PCPβ activity was blocked proved to be non-viable and no sign of 935 
viral RNA synthesis could be detected, indicating that the correct processing of the nsp1β/nsp2 936 
cleavage site is essential for PRRSV genome replication. In conclusion, the data presented here 937 
shows that a productive PRRSV life cycle depends on the correct processing of both the nsp1α 938 
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/nsp1β and nsp1β/nsp2 junctions (Kroese et al., 2008). Cleavage sites between nsp1α/nsp1β and 939 
nsp1β/nsp2 were identified by protein microsequencing analysis (Chen et al., 2010). The 940 
cleavage site between nsp1α/nsp1β is located at position 180M/181A (Figure 2) and is conserved 941 
among different NA PRRSV strains (Chen et al., 2010). The cleavage site between nsp1β/nsp2 is 942 
located at position 383G/384A (Figure 2) and is well conserved among different PRRSV isolates 943 
(Chen et al., 2010). The replicase polyproteins of PRRSV are predicted to be cleaved into 13 nsp 944 
by the nsp4 main proteinase and three accessory proteinases residing in nsp1α, nsp1β and nsp2 945 
(van Aken et al., 2006a; van Aken et al., 2006b; van Aken et al., 2006c; Ziebuhr et al., 2000). 946 
PCPα directs the release of nsp1α, whereas the liberation of nsp1β depends on the activities of 947 
PCPα and a second proteinase, PCPβ. A third cysteine proteinase, residing in the N-terminal 948 
domain of nsp2, is responsible for the cleavage of the nsp2/nsp3 site (den Boon et al., 1995; 949 
Snijder et al., 1995a, b; Snijder, 1998). Viral papain-like proteinases are characterized by a 950 
catalytic dyad that consists of a nucleophilic cysteine residue and a downstream histidine (Figure 951 
2).  952 
Among the nsp, the nsp2 multidomain is the largest PRRSV replicative protein and is 953 
predicted to possess approximately 980 aa (Allende et al., 1999; Ziebuhr et al., 2000). Three 954 
major domains could be discerned through the alignment of arterivirus nsp2 proteins: 1) an N-955 
terminal cysteine proteinase domain (PL2), 2) a functionally unspecified middle region, and 3) a 956 
hydrophobic transmembrane (TM) region near the C terminus (Han et al., 2006; Ziebuhr et al., 957 
2000). The C-terminal end of nsp2 forms a non-covalent interaction with nsp3, which together 958 
form a scaffolding complex that supports the formation of double membrane vesicles and virus 959 
replication complexes (Snijder, Meulenberg, 1998; Snijder et al., 2001; Snijder et al., 1994; 960 
Ziebuhr et al., 2000). The PL2 of PRRSV nsp2 (Figure 2) is predicted to act on the potential 961 
  45
substrates at the nsp2-nsp3 junction and two potential cleavage sites have been proposed: 962 
981G/G and 1196G/G/G (Allende et al., 1999; Ziebuhr et al., 2000), according to the knowledge 963 
obtained from nsp2 of EAV, which prefers G/G dipeptides (Snijder et al., 1995b, Snijder, 1998). 964 
The function of PRRSV nsp2 in the virus life cycle is poorly understood, while EAV nsp2 has 965 
been shown to be involved in the generation of double-membrane vesicles together with nsp3, 966 
also functions as a co-factor with nsp4 serine protease to process the other cleavage products 967 
(Snijder et al., 1994; Snijder, 1995a, b; Wassenaar et al., 1997). Although PRRSV nsp2 968 
possesses potential enzymatic function, it has been shown to be highly heterogeneous and 969 
variable (Table 1). It is well documented that PRRSV nsp2 accounts for the major genetic 970 
differences (with GP5 major structural protein) between NA and EU PRRSV strains, sharing less 971 
than 40% similarity at the aa level (Allende et al., 1999; Nelsen et al., 1999). In addition, nsp2 is 972 
also the key region for genomic differentiation between PRRSV genotypes NA and EU strains. 973 
Natural mutations, insertions, or, most notably, deletions are seen in the middle region or near 974 
the N-terminal region of the nsp2 protein in field strains, while the putative PL2 domain, 975 
predicted TM domain, as well as the predicted cleavage sites of nsp2 remain well conserved 976 
(Allende et al., 1999; Fang et al., 2004; Gao et al., 2004; Han et al., 2006; Nelsen et al., 1999; 977 
Ropp et al., 2004; Shen et al., 2000).  978 
Areas in nsp2 with deletions and aa hypervariability are predicted to be immunologically 979 
important (Fang et al., 2007). During the past 2 years, an atypical clinical outbreak, caused by a 980 
highly pathogenic PRRSV strain with a unique 30 aa deletion in its nsp2 coding region, was 981 
implicated in China (Li et al., 2007; Tian et al., 2007; Zhou et al., 2008). In the field, the virus 982 
was associated with high mortality/morbidity in pigs of all ages, with mortality as high as 90% in 983 
some herds. The mechanism for enhanced virulence was not determined but seems to be 984 
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associated to nsp2 30 aa deletion (Li et al., 2007). Recently, few full-length infectious cDNA 985 
clones were generated, in which the nsp2 region containing the 30 aa deletion was replaced by 986 
the corresponding region of the low virulence PRRSV strain (Zhou et al., 2009). The researchers 987 
concluded that the 30 aa deletion is not related to the virulence of the highly pathogenic PRRSV 988 
that recently emerged in China (Zhou et al., 2009).  989 
The nsp2 gene may be an ideal marker for monitoring the genetic variation and for 990 
developing differential diagnostic tests. Since this region tolerates mutations, including insertions 991 
and deletions, nsp2 may represent the ideal site for the development of recombinant marker 992 
vaccines derived from infectious clones (Fang et al., 2004). In that regards a number of studies 993 
have indicated that PRRSV nsp2 is able to tolerate aa deletion and foreign gene insertion (Fang 994 
et al., 2004; Fang et al., 2006; Gao et al., 2004; Han et al., 2007; Kim et al., 2007; Ran et al., 995 
2008; Tian et al., 2007) and is then an excellent gene candidate for modifications (de Lima et al., 996 
2008; Fang et al., 2006; Kim et al., 2007).  997 
PRRSV non-structural proteins play a key role in processing and maturation of the 998 
repertoire of structural and nsp’s of the virion, but little is known about the anti-nsp immune 999 
response. In one recent study (Johnson et al., 2007), it was hypothesized that pronounced 1000 
antibody responses are generated against PRRSV nsp1 and nsp2. Accordingly, nsp1 and nsp2 1001 
were cloned and expressed, and antibody responses in the sera of infected and vaccinated pigs 1002 
were determined (Johnson et al., 2007). Pigs mounted significant cross-reactive antibody 1003 
responses against nsp1 and nsp2 that appeared equivalent to or greater than the response to N 1004 
protein. Antibody reactivity to nsp1 and N was highly dependent on refolding of denatured 1005 
proteins, suggesting that the porcine antibody response is directed primarily to conformational 1006 
epitopes. The proteins were recognized with sera from pigs infected with PRRSV heterogeneous 1007 
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strains, indicating that multiple epitopes are conserved. Antibody responses against nsp1 and 1008 
nsp2 were much higher than those directed against nsp4 (Johnson et al., 2007). 1009 
PRRSV has been shown to be a poor inducer of interferon (IFN) in vitro and in vivo. 1010 
Recently, several nsp (nsp1, nsp2, nsp4 and nsp11) were identified to downregulate the immune 1011 
response (Beura et al., 2010). They were found to possess an inhibitory effect on interferon-beta 1012 
(IFN-β) promoter activation for which the strongest inhibitory effect was exhibited by nsp1 1013 
followed by, nsp2, nsp11, and nsp4 (Beura et al., 2010). In addition, it was found that nsp1α, 1014 
nsp1β and nsp11 strongly inhibit dsRNA signaling pathways. The nsp1β was found to inhibit 1015 
both IFN regulatory factor 3 (IRF3) and NF-kB-dependent gene induction by dsRNA and Sendai 1016 
virus. Investigation of IRF3 phosphorylation status after dsRNA stimulation showed that nsp1β 1017 
inhibits IRF3 (Ser396) phosphorylation and subsequently its nuclear translocation (Beura et al., 1018 
2010). Another recent report has revealed that nsp1α and nsp1β dramatically inhibit IFN-β 1019 
expression (Chen et al., 2010). This study indicates that nsp1β possesses the ability to inhibit 1020 
both IFN synthesis and its signaling pathway, while nsp1α alone strongly inhibits IFN synthesis. 1021 
The four predicted ORF1b non-structural polypeptides comprise a putative RNA 1022 
dependent RNA polymerase (POL or nsp9), a nsp10 protein (nsp10) which contains a putative 1023 
metal-binding domain (MBD) and nucleoside triphosphate binding or helicase motif (HEL), and 1024 
two proteins of unknown functions (nsp11 and nsp12) (Allende et al., 2000; Allende et al., 1999; 1025 
Bautista et al., 2002; den Boon et al., 1991; Godeny et al., 1993; Gorbalenya, 1989; Herold et al., 1026 
1996; Meulenberg et al., 1993a; Nelsen et al., 1999; Shen et al., 2000; Snijder, Meulenberg, 1027 
1998; van Dinten et al., 1999; van Dinten, 1996; Wootton et al., 2000). PRRSV nsp10 was found 1028 
to possess a thermolabile and pH-sensitive NTPase activity that was modulated by 1029 
polynucleotides and was able to unwind dsRNA in a 5’ to 3’ polarity (Bautista et al., 2002). 1030 
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These results provide the first evidence of the functional properties of PRRSV helicase and 1031 
further support the finding that nidovirus helicases possess properties that distinguish them from 1032 
other viral helicases (Bautista et al., 2002). Based on significant homology in the catalytic 1033 
domains and in predicted cleavage sites of PRRSV strains it was suggested that PRRSV 1034 
polymerase may undergo similar proteolytic processing as that of EAV (Snijder, Meulenberg, 1035 
1998; van Dinten et al., 1999; Wassenaar et al., 1997; Ziebuhr et al., 2000). 1036 
 1037 
Following the first identification of PRRSV in the early 90’s, most of the research was 1038 
oriented toward the study of the viral structural proteins.  During the last five years, an 1039 
increasingly significant number of reports were oriented toward the acquisition of new 1040 
knowledge in regards to the non-structural viral proteins. In accordance with these recent reports, 1041 
it became evident that the nsp play a tremendous role in regards to viral pathogenesis such as the 1042 
immune response down regulation. The nsp ability to inhibit the IFN indicate that they are 1043 
important virulence determinants. Thus, we are now entering a new exciting PRRSV research era 1044 
that will focus on a better understanding of how PRRSV take control of the host immune 1045 
response to its advantage.  1046 
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CONCLUSION 1047 
 1048 
PRRS continues to be an economically devastating disease affecting swine industry 1049 
worldwide. Herein, an overview of current knowledge on virus structural and non-structural 1050 
proteins in regard to viral pathogenesis was given.  1051 
To date, little is known about the biological functions of the individual nsp of PRRSV, 1052 
except that they exhibit replicase, protease and polymerase activities. With the continuing 1053 
emergence of viral strains, the nsp2 replicase protein with is noted mutations, insertions, and 1054 
deletions has become a vital region for monitoring the rapid viral genomic evolution and for 1055 
molecular epidemiology research on PRRSV (Allende et al., 1999; Fang et al., 2004; Fang et al., 1056 
2006; Fang et al., 2007; Gao et al., 2004; Han et al., 2007; Han et al., 2006; Kim et al., 2007; 1057 
Ropp et al., 2004; Yoshii et al., 2008). The PRRSV nsp anti-IFN activity is certainly involved in 1058 
the paradoxical immune response observed in PRRSV infected swine and would explain the 1059 
inability of the host to clear PRRSV. The capability of the PRRSV nsp to interfere with the 1060 
establishment of the innate and cellular antiviral state suggests that nsp are critical virulence 1061 
determinants. In a near future, we could expect that research program involving nsp immune 1062 
regulation of the infected host will provide important insight into the mechanism of PRRSV 1063 
pathogenesis which could lead to new and innovative approaches for the control of PRRSV. In 1064 
regards to viral structural proteins, it has been demonstrated that N, M and GP5 are essential and 1065 
sufficient for particle formation, but that the minor structural proteins are also required for virus 1066 
infectivity (Wieringa et al., 2003; Wieringa et al., 2004; Wissink et al., 2005). The N protein 1067 
seems to be the most immunogenic viral protein and an ideal target for the serological detection 1068 
of infected pigs (Dea et al., 2000b; Denac et al., 1997; Ferrin et al., 2004; Seuberlich et al., 1069 
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2002). Nonetheless, some non-structural viral proteins, such as nsp2, are also highly 1070 
immunogenic (Fang et al., 2004; Johnson et al., 2007; Oleksiewicz et al., 2001a, 2002; 1071 
Oleksiewicz et al., 2001b). In addition, nuclear and/or nucleolar localization of N protein could 1072 
have an important role in cell genes expression regulation (Hiscox, 2002, 2003, 2007; Rowland, 1073 
Yoo, 2003; Uchil et al., 2006; Weidman et al., 2003).  1074 
It is further evident that the current vaccines based on a single PRRSV strain and on 1075 
expression of GP5 alone, are not or only partially effective (Kimman et al., 2009). Viral epitopes 1076 
that are capable of inducing neutralizing antibodies appear to reside on the M, GP2a, GP3, GP4, 1077 
and GP5 proteins (Ansari et al., 2006; Kim, Yoon, 2008; Plagemann, 2006; Yang et al., 2000). Of 1078 
these, neutralizing antibodies to GP5 appear to be most relevant for protection since most of the 1079 
neutralizing Abs found in infected animals are directed against the GP5. Unfortunately, it is also 1080 
one of the most variable proteins between viral strains. Several recent studies using expression of 1081 
the fusion proteins M-GP5 and GP3–GP5, GP4–GP5, or GP3–GP4–GP5 showed that specific 1082 
immune response against GP5 was significantly increased by fusion of proteins compared to 1083 
animal immunized with GP5 alone (Jiang et al., 2006a; Jiang et al., 2008). In addition, it was 1084 
found that glycosylation of GP5 of PRRSV play an important role in escaping or minimizing 1085 
virus-neutralizing antibody response by a N-glycan-shielding mechanism (Kimman et al., 2009). 1086 
Therefore, the glycosylation of GP5 diminishes the immunogenicity of the nearby enclosed 1087 
neutralizing epitope, and are thus critical for the induction or evasion of a neutralizing antibody 1088 
response. Taken these results together, we can conclude that for vaccine development, GP5 1089 
should be optimized in its ability to induce neutralizing antibodies by allowing its fusion with 1090 
other viral proteins or by reducing its glycosylation state.  1091 
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The virulence of PRRSV is considered to be associated with multiple factors such as, host 1092 
genetic, viral genetic, environment, concomitant infections etc., and consequently it is not easy to 1093 
identify the determinant regions in the genome of PRRSV involved in the viral virulence (Wang 1094 
et al., 2008). However, searching any viral genomic regions or viral genes related to PRRSV 1095 
virulence is an essential step toward making a contribution to the understanding of the 1096 
pathogenicity of PRRSV. In order to determine virulence associated genes in PRRSV, reverse 1097 
genetic has been abundantly used (Kwon et al., 2008; Wang et al., 2008). Using this 1098 
experimental approach, it was found that PRRSV virulence is multigenic and resides in both the 1099 
non-structural and structural viral proteins (Kwon et al., 2008; Wang et al., 2008).  1100 
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FIGURES LEGENDS 1987 
 1988 
Figure 1. Schematic representation of the PRRSV particle. The location of the structural 1989 
proteins: GP2a, E, GP3, GP4, GP5, M and N (encoded by ORFs 2-7) are shown. The virion 1990 
possesses a non-segmented single-strand RNA genome, enclosed into a nucleocapsid protein 1991 
(N), yielding a helicoidal capsid structure. The N protein is the sole component of the viral 1992 
capsid and interacts with itself through covalent and non-covalent interactions (homodimer). The 1993 
major envelope viral protein (GP5) forms a heterodimer structure with the membrane non-1994 
glycosylated protein (M) which dominates the virion surface. The minor structural proteins 1995 
(GP2a, E, GP3 and GP4) are incorporated into virions as a multimeric complex. The minor 1996 
structural viral proteins multimeric complex also interacts with the GP5-M heterodimer (not 1997 
illustrated). Although the GP3 is a structural viral protein, it has been reported once that the GP3 1998 
is a non-structural and secreted viral protein (which suggest that it could be a strain dependent 1999 
phenomenon). 2000 
 2001 
Figure 2.  Schematic representation of the PRRSV genome organization and replication. 2002 
The replicase 1a and 1ab polyproteins (ppla and pp1ab) are expressed from the genomic viral 2003 
RNA. The filled circle indicates the ribosomal frameshift site, and the filled box indicates the 2004 
leader sequence. The structural proteins are expressed from a nested set of subgenomic mRNAs, 2005 
RNAs 2-7, that contain a common 5’ leader sequence. The pp1a is predicted to be cleaved at 2006 
eight sites to form nine non-structural proteins (nsp): nsp1α, nsp1β, and nsp2 to nsp8. Proteolytic 2007 
cleavage of the ORF1b gene portion of the pp1ab generates products nsp9 through nsp12. The 2008 
processing of pp1a and pp1ab is mediated by accessory proteinases located in nsp1 (papain-like 2009 
cysteine proteinases: PCPα and PCPβ) and nsp2 (chymotrypsin-like cysteine protease: PL2pro); 2010 
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and the main serine proteinase located in nsp4 (the serine/3C-like proteinase: 3CLpro). PCPα 2011 
and PCPβ are responsible for the autoproteolytic release of the nsp1α and nsp1β, respectively. In 2012 
addition nsp1 contain zinc-finger motif (ZF) required for subgenomic mRNA transcription. 2013 
Predicted catalytic dyads of both PCP domains and the estimated positions of their respective 2014 
nsp1α/nsp1β and nsp1β/nsp2 cleavage site are illustrated. 2015 
 2016 
Figure 3.  PRRSV N protein schematic model of the North American isolates. The numbers 2017 
identify the amino acids positions covered by each domain. I-V: five domains of antigenic 2018 
importance (30-52; 37-52; 52-69; 69-112 and 112-123); 23-Cys: identifies the location of the 2019 
conserved cysteine residue involved in the intermolecular disulfide bonds N protein homodimer 2020 
formation; 120-Ser: identifies the location of a serine residue that is a phosphorylation target; 2021 
NLS-1: Nuclear localisation signal- 1 or cryptic NLS; NLS-2: Nuclear localisation signal -2 or 2022 
fonctional NLS; NoLS: Nuclear localisation signal sequence. This figure is adapted from 2023 
Rowland and Yoo, 2003. 2024 
 2025 
Figure 4.  Functional and structural domains of the PRRSV GP5 protein of North 2026 
American isolates. The numbers identify the amino acids positions covered by each domain. 2027 
Conserved (black) and non-conserved (grey) glycolysation sites: N30, N34, N44 and N51; the 2028 
conserved cysteine residue involved in the formation the disulfide bond between GP5 and M is 2029 
illustrated: 48-Cys; signal sequence: 1-32; ectodomain: 33-63; transmembrane region: 64-134; 2030 
endodomain: 135-200; Major neutralizing epitope: 36-52; Hypervariable immunodominant non-2031 
neutralizing epitope A (decoy epitope): 27-30; Conserved non-immunodominant neutralizing 2032 
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epitope B: 37-45; Variable regions 57-70 and 121-130; Conserved regions: 41-56, 71-120 and 2033 
131-200. 2034 
  85
Table 1.  PRRSV structural and non-structural proteins characteristics and functions. 
Amino acids 
lengths Proteins Genes 
EU 
strains 
NA 
strains  
Characteristics and functions 
nsp1 385 383 Non-structural multifunctional regulatory protein (processing, transcription, virion biogenesis); proteolytic activities; IFN inhibition. 
nsp2 861 980 
Non-structural, the largest PRRSV replicative protein; the major genetic 
differences  between NA and EU PRRSV strains; ideal marker for monitoring the 
genetic variation and for developing differential diagnostic tests; proteolytic 
activities; IFN inhibition. 
nsp3 447 446 
nsp4 203 204 
nsp5 170 170 
nsp6 16 16 
nsp7 269 259 
nsp8 
ORF1a 
45 45 
Non-structural proteins; proteolytic activities; nsp4: IFN inhibition. 
nsp9 645 640 
nsp10 442 441 
nsp11 224 223 
nsp12 
ORF1b 
152 153 
Non-structural proteins; virus transcription and replication; nsp9: RNA-
dependent RNA polymerase and NTPase; nsp10: helicase; nsp11: IFN inhibition;. 
GP2a ORF2a 249 256 
Minor structural protein; contain 2 two highly conserved putative N-linked 
glycosylation sites; essential for virus infectivity; incorporated into virions as a 
multimeric complex; viral attachment protein. 
E ORF2b 70 73 
Minor unglycosylated and myristoylated structural protein; essential for virus 
infectivity; incorporated into virions as a multimeric complex; possesses ion-
channel like properties and may function as a viroporin in the envelope. 
GP3 ORF3 265 254 
Minor structural protein, one of the most variable PRRSV proteins; highly 
glycosylated with potentially seven N-linked oligosaccharides; its membrane 
topology seems to be strains dependent; highly antigenic and may be involved in 
viral neutralization; essential for virus infectivity; incorporated into virions as a 
multimeric complex. 
GP4 ORF4 183 178 
Minor structural highly glycosylated protein (four N-linked glycosylation sites); 
essential for virus infectivity; key glycoprotein for formation of the multiprotein 
complex incorporated into virions; mediates interaction between multiprotein 
complex of the minor viral glycoproteins and GP5; viral attachment protein and 
may be involved in viral neutralization.  
GP5 ORF5 201 200 
Major structural, transmembrane protein with a variable number of potential N-
glycosylation sites; the most variable structural proteins in the PRRSV genome 
with GP3; involved in virus neutralisation and protection; the covalent association 
of GP5 and M is crucial for virus assembly; involved in the entry of virus into the 
host cells and in the apoptosis phenomenon. 
M ORF6 173 174 
Major unglycosylated structural protein which is the most conserved; play a key 
role in virus assembly and budding; GP5-M heterodimerization is crucial for 
virus infectivity. 
N ORF7 128 123 
Major unglycosylated, phosphorylated and structural protein; highly 
immunogenic and a suitable candidate for the detection of virus-specific 
antibodies and diagnosis of the disease; the sole component of the viral capsid and 
interacts with itself through covalent and non-covalent interactions; able to 
localize in the nucleus/nucleolus and interact with cellular transcription factor. 
ORF: Open reading frames; EU: European PRRSV strains; NA: North American PRRSV strains. 




